Amedeo Smart

Free Medical Literature Service

 

Amedeo

Colorectal Neoplasms
  Free Subscription

Articles published in
Ann Surg Oncol
    May 2024
  1. HUANG Y, Liao F, Chen H, Shu X, et al
    ASO Author Reflections: Self-expanding Metal Stents for Right-Sided Colonic Cancer Obstruction.
    Ann Surg Oncol. 2024;31:3242-3243.
    >> Share

  2. GOMAA I, Aboelmaaty S, Narasimhan AL, Bhatt H, et al
    The Impact of Enhanced Recovery on Long-Term Survival in Rectal Cancer.
    Ann Surg Oncol. 2024;31:3233-3241.
    >> Share

  3. ONO Y, Inoue Y, Ito H, Takahashi Y, et al
    ASO Author Reflections: Advancing Two-Stage Hepatectomy: Laparoscopic Portal Vein Ligation and Embolization for Initially Unresectable Colorectal Liver Metastases.
    Ann Surg Oncol. 2024;31:3114-3115.
    >> Share

  4. HUANG Y, Liao F, Zhan Z, Chen X, et al
    Efficacy and Safety Analysis of Emergency Endoscopic Self-Expanding Metal Stent Placement Without Fluoroscopic Assistance for Right-Sided Colonic Cancer Obstruction.
    Ann Surg Oncol. 2024;31:3212-3221.
    >> Share

  5. GORJI L, Nikahd M, Onuma A, Tsilimigras D, et al
    Comparing Multivisceral Resection with Tumor-only Resection of Liposarcoma Using the Win Ratio.
    Ann Surg Oncol. 2024;31:3389-3396.
    >> Share

  6. SHIN JK, Kim HC, Lee WY, Yun SH, et al
    Is Robotic Surgery Beneficial for Rectal Cancer Patients with Unfavorable Characteristic After Neoadjuvant Chemoradiotherapy?
    Ann Surg Oncol. 2024;31:3203-3211.
    >> Share

  7. FACKCHE NT, Schmocker RK, Nudotor R, Kubi B, et al
    Preoperative CA 19-9 Predicts Disease Progression in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: An Analysis from the US HIPEC Collaborative.
    Ann Surg Oncol. 2024;31:3314-3324.
    >> Share

  8. ONO Y, Inoue Y, Kobayashi K, Sato S, et al
    Laparoscopic Portal Vein Ligation and Embolization During First-Stage Hepatectomy for Initially Unresectable Colorectal Liver Metastases.
    Ann Surg Oncol. 2024;31:3069-3070.
    >> Share

    April 2024
  9. YANG Y, Du Z, Zhang Q
    Letter to Editor regarding article "C-Reactive Protein/Albumin Ratio is an Independent Risk Factor for Recurrence and Survival Following Curative Resection of Stage I-III Colorectal Cancer in Older Patients".
    Ann Surg Oncol. 2024 Apr 10. doi: 10.1245/s10434-024-15263.
    >> Share

  10. BOYEV A, Newhook TE
    ASO Author Reflections: Patients with Recurrence Amenable to Local Therapy for Colorectal Liver Metastases May Experience Improved Survival.
    Ann Surg Oncol. 2024;31:2600-2601.
    >> Share

  11. CHANG WJ, Chen CB, Chang YT, Wen TC, et al
    ASO Author Reflections: Advancements in Laparoscopic Parenchyma-Sparing Liver Resection: Autologous Peritoneal Patch for Middle Hepatic Vein Reconstruction in Colorectal Liver Metastasis.
    Ann Surg Oncol. 2024;31:2598-2599.
    >> Share

  12. CHOI JS, Kim MJ, Shin R, Park JW, et al
    ASO Visual Abstract: Risk Factor Analysis of Lymph Node Metastasis for Rectal Neuroendocrine Tumor: Who Needs a Radical Resection for the Rectal Neuroendocrine Tumor 1-2 cm in Size?
    Ann Surg Oncol. 2024;31:2439.
    >> Share

  13. WACH MM, Nunns G, Hamed A, Derby J, et al
    Normal CEA Levels After Neoadjuvant Chemotherapy and Cytoreduction with Hyperthermic Intraperitoneal Chemoperfusion Predict Improved Survival from Colorectal Peritoneal Metastases.
    Ann Surg Oncol. 2024;31:2391-2400.
    >> Share

  14. SAKANAKA T, Iwamoto H, Matsuda K, Mitani Y, et al
    Double Negativity of MRI-Detected and Pathologically-Diagnosed Extramural Venous Invasion is a Favorable Prognostic Factor for Rectal Cancer.
    Ann Surg Oncol. 2024;31:2425-2438.
    >> Share

  15. BOYEV A, Tzeng CD, Maki H, Arvide EM, et al
    ASO Visual Abstract: Local Therapy Improves Survival for Early Recurrence After Resection of Colorectal Liver Metastases.
    Ann Surg Oncol. 2024;31:2606.
    >> Share

  16. SULLIVAN KM, Whelan RL, DePeralta D, Merchea A, et al
    Reply to Letter to the Editor Concerning "Safety and Efficacy of Oxaliplatin Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Colorectal and Appendiceal Cancer with Peritoneal Metastases: Results of a Multicenter Phase I Trial in the US
    Ann Surg Oncol. 2024;31:2408-2409.
    >> Share

  17. HIRST N, McBride K, Steffens D
    Psychological Interventions in Prehabilitation Randomized Controlled Trials for Patients Undergoing Cancer Surgery: Sufficient or Suboptimal?
    Ann Surg Oncol. 2024;31:2183-2186.
    >> Share

  18. SAKANAKA T, Iwamoto H, Matsuda K, Mitani Y, et al
    ASO Visual Abstract: Double Negativity of MRI-Detected and Pathologically Diagnosed Extramural Venous Invasion is a Favorable Prognostic Factor for Rectal Cancer.
    Ann Surg Oncol. 2024;31:2440-2441.
    >> Share

  19. CHOI JS, Kim MJ, Shin R, Park JW, et al
    Risk Factor Analysis of Lymph Node Metastasis for Rectal Neuroendocrine Tumors: Who Needs a Radical Resection in Rectal Neuroendocrine Tumors Sized 1-2 cm?
    Ann Surg Oncol. 2024;31:2414-2424.
    >> Share

  20. BOYEV A, Tzeng CD, Maki H, Arvide EM, et al
    Local Therapy Improves Survival for Early Recurrence After Resection of Colorectal Liver Metastases.
    Ann Surg Oncol. 2024;31:2547-2556.
    >> Share

  21. CHIU CC
    Letter to the Editor of Annals of Surgical Oncology Concerning "Safety and Efficacy of Oxaliplatin Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Colorectal and Appendiceal Cancer with Peritoneal Metastases: Results of a Multicenter P
    Ann Surg Oncol. 2024;31:2405-2407.
    >> Share

    March 2024
  22. KHAN MMM, Munir MM, Woldesenbet S, Endo Y, et al
    ASO Visual Abstract: Association of COVID-19 Pandemic with Colorectal Cancer Screening: Impact of Race/Ethnicity and Social Vulnerability.
    Ann Surg Oncol. 2024 Mar 12. doi: 10.1245/s10434-024-15140.
    >> Share

  23. BEDRIKOVETSKI S, Traeger L, Fitzsimmons T, Price TJ, et al
    ASO Visual Abstract: Association Between RAS/BRAF Mutations and Complete Response After Total Neoadjuvant Therapy of Patients with Rectal Cancer: A Prospective Multicentered Study.
    Ann Surg Oncol. 2024;31:1698-1699.
    >> Share

  24. RADOMSKI SN, Dunworth M, West JJ, Greer JB, et al
    Intra- and Interpatient Drug Response Heterogeneity Exist in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Nongynecologic Cancers.
    Ann Surg Oncol. 2024;31:1996-2007.
    >> Share

  25. PIKOULIS E, Papaconstantinou D, Pikouli A, Pararas N, et al
    Is Precision Surgery Applicable to Colorectal Liver Metastases? A Systematic Review and Meta-analysis of Studies that Investigate the Association of Surgical Technique with Outcomes in the Context of Distinct Tumor Biology.
    Ann Surg Oncol. 2024;31:1823-1832.
    >> Share

  26. BEDRIKOVETSKI S, Traeger L, Sammour T
    ASO Author Reflections: Impact of RAS Mutations on Total Neoadjuvant Therapy Outcomes in Rectal Cancer.
    Ann Surg Oncol. 2024;31:1692-1693.
    >> Share

  27. BALACHANDRAN R, Thaysen HV, Christensen P, Zachariae R, et al
    Biopsychosocial Late Effects After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Metastases from Colorectal and Appendiceal Cancer: A National Prospective Cohort Study.
    Ann Surg Oncol. 2024;31:1959-1969.
    >> Share

  28. CIFTCI Y, Radomski SN, Johnston FM, Greer JB, et al
    ASO Visual Abstract: Predictors of Financial Toxicity Risk Among Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC).
    Ann Surg Oncol. 2024;31:2016.
    >> Share

  29. BALACHANDRAN R, Thaysen HV, Christensen P, Zachariae R, et al
    ASO Visual Abstract: Biopsychosocial Late Effects After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Metastases from Colorectal and Appendiceal Cancer: A National Prospective Cohort Study.
    Ann Surg Oncol. 2024;31:2014-2015.
    >> Share

  30. MIRZA MB, Smith PM, Wang Y, Naveed A, et al
    Intra-Patient Heterogeneity in Micro-satellite-stable Colorectal Metastases: Does Immunotherapy Have a Role in Colorectal Peritoneal Metastases?
    Ann Surg Oncol. 2024;31:1440-1443.
    >> Share

  31. SARFATY E, Khajoueinejad N, Yu AT, Hiotis S, et al
    ASO Visual Abstract: Actual 5-Year Survival After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Patients with Peritoneal Carcinomatosis of Colorectal Origin.
    Ann Surg Oncol. 2024;31:2021.
    >> Share

  32. BEDRIKOVETSKI S, Traeger L, Fitzsimmons T, Price TJ, et al
    Association Between RAS/BRAF Mutations and Complete Response Following Total Neoadjuvant Therapy in Patients with Rectal Cancer: A Prospective Multicentered Study.
    Ann Surg Oncol. 2024;31:1681-1689.
    >> Share

  33. BALACHANDRAN R, Thaysen HV, Christensen P, Zachariae R, et al
    ASO Author Reflections: Biopsychosocial Late Effects are Frequent and Negatively Impact Quality of Life Following Curatively Intended Surgery for Colorectal and Appendiceal Cancer with Peritoneal Metastases.
    Ann Surg Oncol. 2024;31:1696-1697.
    >> Share

  34. SARFATY E, Cohen NA
    ASO Author Reflections: Achieving Long-Term Survival in Patients with Peritoneal Carcinomatosis of Colorectal Origin.
    Ann Surg Oncol. 2024;31:2010-2011.
    >> Share

  35. WU CY, Ye K
    The Application Prospect of Navigation-Assisted Surgery for Locally Advanced Primary and Recurrent Rectal Cancer is Broad.
    Ann Surg Oncol. 2024;31:1702-1703.
    >> Share

  36. CHANG WJ, Chen CB, Chang YT, Wen TC, et al
    Novel Use of the Falciform Ligament for MHV Reconstruction During Laparoscopic Hepatectomy of Colorectal Liver Metastasis.
    Ann Surg Oncol. 2024;31:1835.
    >> Share

  37. RYU S, Goto K, Imaizumi Y, Nakabayashi Y, et al
    Laparoscopic Colorectal Surgery with Anatomical Recognition with Artificial Intelligence Assistance for Nerves and Dissection Layers.
    Ann Surg Oncol. 2024;31:1690-1691.
    >> Share

  38. KOSEKI Y, Hikage M, Terashima M, Notsu A, et al
    ASO Visual Abstract: The Effectiveness of Screening Total Colonoscopy for Preoperative Patients with Gastric Cancer.
    Ann Surg Oncol. 2024;31:1800-1801.
    >> Share

  39. SARFATY E, Khajoueinejad N, Yu AT, Hiotis S, et al
    Actual 5-Year Survival After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Patients with Peritoneal Carcinomatosis of Colorectal Origin.
    Ann Surg Oncol. 2024;31:1970-1979.
    >> Share

  40. TONELLO M, Baratti D, Sammartino P, Di Giorgio A, et al
    ASO Visual Abstract: Is Systemic Chemotherapy Useful in Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Colorectal Peritoneal Metastases? A Propensity-Score Analysis.
    Ann Surg Oncol. 2024;31:2017-2018.
    >> Share

  41. TONELLO M, Sommariva A
    ASO Author Reflections: Is Systemic Chemotherapy Useful in Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Colorectal Peritoneal Metastases? A Propensity Score Analysis.
    Ann Surg Oncol. 2024;31:2008-2009.
    >> Share

    February 2024
  42. KHAN MMM, Munir MM, Pawlik TM
    ASO Author Reflections: Association of COVID-19 Pandemic with Colorectal Cancer Screening: Impact of Race/Ethnicity and Social Vulnerability.
    Ann Surg Oncol. 2024 Feb 21. doi: 10.1245/s10434-024-15097.
    >> Share

  43. MEIER J, Murimwa G, Nehrubabu M, DiMartino L, et al
    ASO Visual Abstract: Effect of Hospital Cancer Designation on Use of Multimodal Therapy and Survival of Patients with Metastatic Colorectal Cancer: A State-Wide Analysis.
    Ann Surg Oncol. 2024 Feb 17. doi: 10.1245/s10434-024-15015.
    >> Share

  44. KHAN MMM, Munir MM, Woldesenbet S, Endo Y, et al
    Association of COVID-19 Pandemic with Colorectal Cancer Screening: Impact of Race/Ethnicity and Social Vulnerability.
    Ann Surg Oncol. 2024 Feb 15. doi: 10.1245/s10434-024-15029.
    >> Share

  45. MCDONALD HG, Zaki OA, Wright MJ, Jayswal R, et al
    Phase I Safety and Feasibility Pilot of Hepatic Artery Infusion Chemotherapy in a Rural Catchment Area Using The Codman Vascular Catheter with The Medtronic SynchroMed II Pump for Intrahepatic Cancers.
    Ann Surg Oncol. 2024;31:1252-1263.
    >> Share

  46. DIAZ A, Pawlik T
    Association of ICD-10 Clinical Modification Codes for Social Determinants of Health with Surgical Outcomes and Hospital Charges Among Cancer Patients.
    Ann Surg Oncol. 2024;31:1171-1177.
    >> Share

  47. TIPMANEE P, Malakorn S
    Laparoscopic Total Pelvic Exenteration with En-bloc Lateral Pelvic Lymph Node Dissection with Colonic Flap Pelvic Reconstruction.
    Ann Surg Oncol. 2024;31:1087-1088.
    >> Share

  48. KOSEKI Y, Hikage M, Terashima M, Notsu A, et al
    The Effectiveness of Screening Total Colonoscopy for Preoperative Patients with Gastric Cancer.
    Ann Surg Oncol. 2024;31:762-771.
    >> Share

    January 2024
  49. GRANGE R, Rousset P, Williet N, Guesnon M, et al
    ASO Visual Abstract: Metastatic Colorectal Cancer Treated with Combined Liver Resection, Cytoreductive Surgery, and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Predictive Factors for Early Recurrence.
    Ann Surg Oncol. 2024 Jan 29. doi: 10.1245/s10434-024-14923.
    >> Share

  50. BEKKI T, Shimomura M, Hattori M, Sato S, et al
    C-Reactive Protein/Albumin Ratio Is an Independent Risk Factor for Recurrence and Survival Following Curative Resection of Stage I-III Colorectal Cancer in Older Patients.
    Ann Surg Oncol. 2024 Jan 27. doi: 10.1245/s10434-024-14961.
    >> Share

  51. MEIER J, Murimwa G, Nehrubabu M, DiMartino L, et al
    Effect of Hospital Cancer Designation on use of Multimodal Therapy and Survival of Metastatic Colorectal Cancer: A State-Wide Analysis.
    Ann Surg Oncol. 2024 Jan 20. doi: 10.1245/s10434-023-14859.
    >> Share

  52. KEPENEKIAN V, Grange R, Passot G, Glehen O, et al
    ASO Author Reflections: Selected Multisite Metastatic Colorectal Cancer Patients May Benefit from Radical Multimodal Treatment.
    Ann Surg Oncol. 2024 Jan 19. doi: 10.1245/s10434-024-14929.
    >> Share

  53. DEGIULI M, Aguilar HAR, Solej M, Azzolina D, et al
    ASO Visual Abstract: A Randomized Phase III Trial of Complete Mesocolic Excision in Comparison with Conventional Surgery for Right Colon Cancer: Interim Analysis of a Nationwide Multicenter Study of the Italian Society of Surgical Oncology Colorectal
    Ann Surg Oncol. 2024 Jan 10. doi: 10.1245/s10434-023-14794.
    >> Share

  54. GRANGE R, Rousset P, Williet N, Guesnon M, et al
    Metastatic Colorectal Cancer Treated with Combined Liver Resection, Cytoreductive Surgery, and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Predictive Factors for Early Recurrence.
    Ann Surg Oncol. 2024 Jan 3. doi: 10.1245/s10434-023-14840.
    >> Share

  55. SARKAR J, Attwood K, Schwarz RE
    ASO Visual Abstract: Perioperative Chemotherapy is Associated with Superior Overall Survival in Patients with Synchronous Colorectal Liver Metastases.
    Ann Surg Oncol. 2024;31:158.
    >> Share

  56. THOMAS KK, Francescatti AB, Vreeland TJ, Teshome MK, et al
    Standardization of Colon Resection for Cancer: An Overview of the American College of Surgeons Commission on Cancer Standard 5.6.
    Ann Surg Oncol. 2024;31:6-9.
    >> Share

  57. SARKAR J, Schwarz RE
    ASO Author Reflections: Optimizing Treatment Sequencing in Synchronous Resectable Colorectal Liver Metastases.
    Ann Surg Oncol. 2024;31:156-157.
    >> Share

  58. TONELLO M, Baratti D, Sammartino P, Di Giorgio A, et al
    Is Systemic Chemotherapy Useful in Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Colorectal Peritoneal Metastases? A Propensity-Score Analysis.
    Ann Surg Oncol. 2024;31:594-604.
    >> Share

  59. BRANES A, Karanicolas P
    Adjuvant Hepatic Artery Infusion Chemotherapy: Still Swimming in Dark Water?
    Ann Surg Oncol. 2024;31:19-20.
    >> Share

  60. VIERRA M, Bansal VV, Morgan RB, Witmer HDD, et al
    ASO Visual Abstract: Fragmentation of Care in Patients with Peritoneal Metastases Undergoing Cytoreductive Surgery.
    Ann Surg Oncol. 2024;31:657-658.
    >> Share

  61. VIERRA M, Bansal VV, Shergill A, Turaga KK, et al
    ASO Author Reflections: Fragmented Care in Patients with Peritoneal Metastases.
    Ann Surg Oncol. 2024;31:655-656.
    >> Share

  62. VIERRA M, Bansal VV, Morgan RB, Witmer HDD, et al
    Fragmentation of Care in Patients with Peritoneal Metastases Undergoing Cytoreductive Surgery.
    Ann Surg Oncol. 2024;31:645-654.
    >> Share

    December 2023
  63. DEGIULI M, Aguilar AHR, Solej M, Azzolina D, et al
    A Randomized Phase III Trial of Complete Mesocolic Excision Compared with Conventional Surgery for Right Colon Cancer: Interim Analysis of a Nationwide Multicenter Study of the Italian Society of Surgical Oncology Colorectal Cancer Network (CoME-in tr
    Ann Surg Oncol. 2023 Dec 12. doi: 10.1245/s10434-023-14664.
    >> Share

  64. DEGIULI M, Azzolina D, Corcione F, Bracale U, et al
    ASO Author Reflections: Complete Mesocolic Excision Versus Conventional Surgery for Right Colon Cancer (CoME-in trial): An Interim Analysis of a Multicenter, Randomized, Controlled Trial.
    Ann Surg Oncol. 2023 Dec 12. doi: 10.1245/s10434-023-14771.
    >> Share

  65. BUCHHEIT JT, Merkow RP
    ASO Author Reflections: Disparities in Colon Cancer Outcomes Exist Irrespective of Hospital Performance-System-Wide Changes Are Needed to Help Close the Gap.
    Ann Surg Oncol. 2023 Dec 12. doi: 10.1245/s10434-023-14706.
    >> Share

  66. SAWADA A, Ohira M, Hatanaka KC, Matsui H, et al
    Expression Analysis of Early Metastatic Seeding of Colorectal Cancer.
    Ann Surg Oncol. 2023 Dec 8. doi: 10.1245/s10434-023-14714.
    >> Share

  67. BUCHHEIT JT, Silver CM, Huang R, Hu YY, et al
    ASO Visual Abstract: Association Between Racial and Socioeconomic Disparities and Hospital Performance in Treatment and Outcomes for Patients with Colon Cancer.
    Ann Surg Oncol. 2023 Dec 8. doi: 10.1245/s10434-023-14743.
    >> Share

  68. BUCHHEIT JT, Silver CM, Huang R, Hu YY, et al
    Association Between Racial and Socioeconomic Disparities and Hospital Performance in Treatment and Outcomes for Patients with Colon Cancer.
    Ann Surg Oncol. 2023 Dec 7. doi: 10.1245/s10434-023-14607.
    >> Share

  69. KOSEKI Y, Hikage M, Terashima M, Notsu A, et al
    ASO Author Reflections: Significance of Colorectal Cancer Screening Through Preoperative Total Colonoscopy for Gastric Cancer.
    Ann Surg Oncol. 2023 Dec 4. doi: 10.1245/s10434-023-14641.
    >> Share

  70. FILIPE WF, Meyer YM, Buisman FE, van den Braak RRJC, et al
    The Effect of Histopathological Growth Patterns of Colorectal Liver Metastases on the Survival Benefit of Adjuvant Hepatic Arterial Infusion Pump Chemotherapy.
    Ann Surg Oncol. 2023;30:7996-8005.
    >> Share

  71. SARKAR J, Attwood K, Schwarz RE
    Perioperative Chemotherapy is Associated with Superior Overall Survival in Patients with Synchronous Colorectal Liver Metastases.
    Ann Surg Oncol. 2023;30:7986-7995.
    >> Share

  72. STANDRING O, Gholami S
    First-line Hepatic Artery Infusion for Unresectable CLM Works, but Will We Ever Get There?
    Ann Surg Oncol. 2023;30:7918-7920.
    >> Share

  73. JUDGE SJ, Ghalambor T, Cavnar MJ, Lidsky ME, et al
    ASO Visual Abstract: Current Practices in Hepatic Artery Infusion (HAI) Chemotherapy-An International Survey of the HAI Consortium Research Network.
    Ann Surg Oncol. 2023;30:8021-8022.
    >> Share

  74. SUN BJ, Yue TM, Xu N, Fowler C, et al
    ASO Visual Abstract: Impact of Successful Implementation of an Enhanced Recovery After Surgery (ERAS) Protocol for Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC).
    Ann Surg Oncol. 2023;30:8177.
    >> Share

  75. ENGLUM BR, Sahoo S, Mayorga-Carlin M, Hayssen H, et al
    Growing Deficit in New Cancer Diagnoses 2 Years Into the COVID-19 Pandemic: A National Multicenter Study.
    Ann Surg Oncol. 2023;30:8509-8518.
    >> Share

  76. SUN BJ, Yue TM, Xu N, Fowler C, et al
    Impact of Successful Implementation of an Enhanced Recovery After Surgery Protocol for Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
    Ann Surg Oncol. 2023;30:8156-8165.
    >> Share

  77. WU H, Ma W, Jiang C, Li N, et al
    Heterogeneity and Adjuvant Therapeutic Approaches in MSI-H/dMMR Resectable Gastric Cancer: Emerging Trends in Immunotherapy.
    Ann Surg Oncol. 2023;30:8572-8587.
    >> Share

  78. VERHEIJ FS, Kuhlmann KFD, Silliman DR, Soares KC, et al
    ASO Visual Abstract: Combined Hepatic Artery Infusion Pump and Systemic Chemotherapy in the Modern Era for Chemotherapy-Naive Patients with Unresectable Colorectal Liver Metastases.
    Ann Surg Oncol. 2023;30:8014-8015.
    >> Share

  79. VERHEIJ FS, Kuhlmann KFD, Silliman DR, Soares KC, et al
    Combined Hepatic Arterial Infusion Pump and Systemic Chemotherapy in the Modern Era for Chemotherapy-Naive Patients with Unresectable Colorectal Liver Metastases.
    Ann Surg Oncol. 2023;30:7950-7959.
    >> Share

    November 2023
  80. WEHRLE CJ, Fujiki M, Schlegel A, Whitsett Linganna M, et al
    Update to 'A Contemporary Systematic Review on Liver Transplantation for Unresectable Liver Metastasis of Colorectal Cancer'.
    Ann Surg Oncol. 2023 Nov 23. doi: 10.1245/s10434-023-14611.
    >> Share

  81. TRAN CG, Goffredo P, Mott SL, Suraju MO, et al
    ASO Visual Abstract: Conditional Survival After Diagnosis of Non-metastatic Colon Cancer: Impact of Laterality, MSI, and KRAS Status.
    Ann Surg Oncol. 2023 Nov 17. doi: 10.1245/s10434-023-14599.
    >> Share

  82. HUBNER M, van Der Speeten K, Govaerts K, de Hingh I, et al
    2022 Peritoneal Surface Oncology Group International Consensus on HIPEC Regimens for Peritoneal Malignancies: Colorectal Cancer.
    Ann Surg Oncol. 2023 Nov 8. doi: 10.1245/s10434-023-14368.
    >> Share

  83. WEHRLE CJ, Seavey CN, Chang J, Stackhouse K, et al
    Neoadjuvant Gastric Score: How Response to Neoadjuvant Chemotherapy Affects Overall Survival and Adjuvant Benefit.
    Ann Surg Oncol. 2023;30:7240-7250.
    >> Share

  84. KUBOTA S, Miura T, Wakiya T, Yoshizawa T, et al
    ASO Visual Abstract: Exploration of Malignant Characteristics in Neoadjuvant Chemotherapy-Resistant Rectal Cancer, Focusing on Extramural Lesions.
    Ann Surg Oncol. 2023;30:7639-7640.
    >> Share

  85. SEGURA-SAMPEDRO JJ, Morales-Soriano R, Rodriguez-Pino JC, Pineno Flores C, et al
    Antiperistaltic Transverse Coloplasty: A Salvage Procedure in Extensive Bowel and Colorectal Resections to Avoid Intestinal Failure.
    Ann Surg Oncol. 2023;30:7236-7239.
    >> Share

  86. WINICKI NM, Radomski SN, Florissi IS, Cloyd JM, et al
    Neighborhood-Level Socioeconomic Disadvantage Predicts Outcomes in Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Malignancy.
    Ann Surg Oncol. 2023;30:7840-7847.
    >> Share

  87. RAOOF M, Whelan RL, Sullivan KM, Ruel C, et al
    ASO Visual Abstract: Safety and Efficacy of Oxaliplatin Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Colorectal and Appendiceal Cancer with Peritoneal Metastases: Results of a Multicenter Phase I Trial in the United States.
    Ann Surg Oncol. 2023;30:7869-7870.
    >> Share

  88. KUBOTA S, Miura T, Wakiya T, Yoshizawa T, et al
    Exploration of Malignant Characteristics in Neoadjuvant Chemotherapy-Resistant Rectal Cancer, Focusing on Extramural Lesions.
    Ann Surg Oncol. 2023;30:7612-7623.
    >> Share

  89. KOBAYASHI K, Ono Y, Kitano Y, Oba A, et al
    Prognostic Impact of Tumor Markers (CEA and CA19-9) on Patients with Resectable Colorectal Liver Metastases Stratified by Tumor Number and Size: Potentially Valuable Biologic Markers for Preoperative Treatment.
    Ann Surg Oncol. 2023;30:7338-7347.
    >> Share

  90. GOFFREDO P, Tran CG, Hassan I
    ASO Author Reflections: Tailoring Surveillance to Tumor Biology: KRAS and Conditional Survival in Colon Cancer.
    Ann Surg Oncol. 2023 Nov 1. doi: 10.1245/s10434-023-14537.
    >> Share

  91. RAOOF M, Whelan RL, Sullivan KM, Ruel C, et al
    Safety and Efficacy of Oxaliplatin Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Colorectal and Appendiceal Cancer with Peritoneal Metastases: Results of a Multicenter Phase I Trial in the USA.
    Ann Surg Oncol. 2023;30:7814-7824.
    >> Share

  92. SOLBAKKEN AM, Sellevold S, Spasojevic M, Julsrud L, et al
    Navigation-Assisted Surgery for Locally Advanced Primary and Recurrent Rectal Cancer.
    Ann Surg Oncol. 2023;30:7602-7611.
    >> Share

    October 2023
  93. SONAL S, Jain B, Bajaj SS, Dee EC, et al
    Trends and Determinants of Location of Death Due to Colorectal Cancer in the United States : A Nationwide Study.
    Ann Surg Oncol. 2023 Oct 31. doi: 10.1245/s10434-023-14337.
    >> Share

  94. ZHENG X, Cen W, Zhu J, Ye L, et al
    ASO Visual Abstract: Prognostic Value of Tumor Deposits in Stage III Colorectal Cancer Patients with Different N stages: A Population-Based, Retrospective, Cohort Study.
    Ann Surg Oncol. 2023 Oct 30. doi: 10.1245/s10434-023-14480.
    >> Share

  95. SONAL S, Jain B, Bajaj SS, Dee EC, et al
    ASO Visual Abstract: Trends and Determinants of Location of Death Due to Colorectal Cancer in the USA: A Nationwide Study.
    Ann Surg Oncol. 2023 Oct 29. doi: 10.1245/s10434-023-14380.
    >> Share

  96. SONAL S, Berger DL
    ASO Author Reflections: Socio-demographic Disparities in Locations of Death Due to Colorectal Cancer.
    Ann Surg Oncol. 2023 Oct 23. doi: 10.1245/s10434-023-14428.
    >> Share

  97. TRAN CG, Goffredo P, Mott SL, Suraju MO, et al
    Conditional Overall Survival After Diagnosis of Non-Metastatic Colon Cancer: Impact of Laterality, MSI, and KRAS Status.
    Ann Surg Oncol. 2023 Oct 19. doi: 10.1245/s10434-023-14443.
    >> Share

  98. ZHENG X, Ye L
    ASO Author Reflections: The Impact of Tumor Deposits on Survival of Patients with Stage III Colorectal Cancer.
    Ann Surg Oncol. 2023 Oct 15. doi: 10.1245/s10434-023-14399.
    >> Share

  99. HAKKI L, Khan A, Gonen M, Stadler Z, et al
    ASO Visual Abstract: Lymph Node Metastases and Associated Recurrence-Free Survival in Microsatellite Stable and Unstable Colon Cancer.
    Ann Surg Oncol. 2023 Oct 3. doi: 10.1245/s10434-023-14384.
    >> Share

  100. ZHENG X, Cen W, Zhu J, Ye L, et al
    Prognostic Value of Tumor Deposits in Stage III Colorectal Cancer Patients with Different N Stages: A Population-Based, Retrospective, Cohort Study.
    Ann Surg Oncol. 2023 Oct 2. doi: 10.1245/s10434-023-14338.
    >> Share

  101. KARAGKOUNIS G, McIntyre SM, Wang T, Chou JF, et al
    ASO Visual Abstract: Rates and Patterns of Recurrence After Microwave Ablation of Colorectal Liver Metastases: A per-Lesion Analysis of 416 Tumors in the Era of 2.45 GHz Generators.
    Ann Surg Oncol. 2023;30:6579-6580.
    >> Share

  102. SHIMURA Y, Komatsu S, Minami H, Fukumoto T, et al
    ASO Author Reflections: Can the Total Tumor Volume be an Indicator for Optimal Treatment Strategy in Patients with Colorectal Liver Metastases?
    Ann Surg Oncol. 2023;30:6611-6612.
    >> Share

  103. SHIMURA Y, Komatsu S, Nagatani Y, Funakoshi Y, et al
    ASO Visual Abstract: The Usefulness of Total Tumor Volume as a Prognostic Factor and in Selecting the Optimal Treatment Strategy of Chemotherapeutic Intervention in Patients with Colorectal Liver Metastases.
    Ann Surg Oncol. 2023;30:6613-6614.
    >> Share

  104. SHIMURA Y, Komatsu S, Nagatani Y, Funakoshi Y, et al
    The Usefulness of Total Tumor Volume as a Prognostic Factor and in Selecting the Optimal Treatment Strategy of Chemotherapeutic Intervention in Patients with Colorectal Liver Metastases.
    Ann Surg Oncol. 2023;30:6603-6610.
    >> Share

  105. KARAGKOUNIS G, McIntyre SM, Wang T, Chou JF, et al
    Rates and Patterns of Recurrence After Microwave Ablation of Colorectal Liver Metastases: A Per Lesion Analysis of 416 Tumors in the Era of 2.45 GHz Generators.
    Ann Surg Oncol. 2023;30:6571-6578.
    >> Share

  106. PHAM H, Dixon E
    Integration of Next-Generation Sequencing in the Surgical Management of Colorectal Liver Metastasis.
    Ann Surg Oncol. 2023;30:6815-6823.
    >> Share

    September 2023
  107. KHAN A, Hakki L, Weiser MR
    ASO Author Reflections: Microsatellite Unstable Colon Cancer, Lymph Node Metastases, and Risk of Recurrence.
    Ann Surg Oncol. 2023 Sep 27. doi: 10.1245/s10434-023-14359.
    >> Share

  108. HAKKI L, Khan A, Gonen M, Stadler Z, et al
    Lymph Node Metastases and Associated Recurrence-Free Survival in Microsatellite Stable and Unstable Colon Cancer.
    Ann Surg Oncol. 2023 Sep 12. doi: 10.1245/s10434-023-14270.
    >> Share

  109. KUNITOMO A, Ouchi A
    ASO Author Reflections: Localized Synchronous and Metachronous Peritoneal Metastases from Colorectal Cancer-Are They Candidates for Radical Resection?
    Ann Surg Oncol. 2023 Sep 5. doi: 10.1245/s10434-023-14264.
    >> Share

  110. ZMUC J, Heil J, Herfarth C, Bechstein WO, et al
    ASO Visual Abstract: Chemo- and Targeted Therapy Strategies in Patients with Un- or Borderline Resectable Metastatic Colorectal Cancer-Evidence for a Lack of Focus on Resection Rates.
    Ann Surg Oncol. 2023 Sep 4. doi: 10.1245/s10434-023-14224.
    >> Share

  111. LIU M, Wei AC
    Colorectal Liver Metastases: Exploring the Extent of Agreement.
    Ann Surg Oncol. 2023;30:5316-5317.
    >> Share

  112. SLUCKIN TC, Hazen SJA, Horsthuis K, Beets-Tan RGH, et al
    ASO Visual Abstract: Evaluation of National Surgical Practice for Lateral Lymph Nodes in Rectal Cancer in an Untrained Setting.
    Ann Surg Oncol. 2023;30:5486-5488.
    >> Share

  113. MAKI H, Ayabe RI, Nishioka Y, Konishi T, et al
    ASO Visual Abstract: Hepatectomy Before Primary Tumor Resection as the Preferred Approach for Synchronous Liver Metastases from Rectal Cancer.
    Ann Surg Oncol. 2023;30:5403-5404.
    >> Share

  114. SLUCKIN TC, Hazen SJA, Horsthuis K, Beets-Tan RGH, et al
    Evaluation of National Surgical Practice for Lateral Lymph Nodes in Rectal Cancer in an Untrained Setting.
    Ann Surg Oncol. 2023;30:5472-5485.
    >> Share

  115. MAKI H, Ayabe RI, Nishioka Y, Konishi T, et al
    ASO Author Reflections: The Patient First Approach for Synchronous Liver Metastases from Rectal Cancer.
    Ann Surg Oncol. 2023;30:5401-5402.
    >> Share

  116. FROMER MW, Scoggins CR, Egger ME, Philips P, et al
    Reply to: "Current Challenges in Defining Futile Liver Resection and Predicting Early Recurrence After Curative-Intent Treatment for Colorectal Liver Metastases", by Wong, Geoffrey Yuet Mun et al.
    Ann Surg Oncol. 2023;30:5461-5462.
    >> Share

  117. MAKI H, Ayabe RI, Nishioka Y, Konishi T, et al
    Hepatectomy Before Primary Tumor Resection as Preferred Approach for Synchronous Liver Metastases from Rectal Cancer.
    Ann Surg Oncol. 2023;30:5390-5400.
    >> Share

  118. KALADY MF, Steele SR
    Top Colorectal Articles from 2021 to Inform Your Cancer Practice.
    Ann Surg Oncol. 2023;30:5489-5494.
    >> Share

  119. KONISHI T
    Evaluation of National Surgical Practice for Lateral Lymph Nodes in Rectal Cancer in an Untrained Setting: Time to Collaborate for Universal Consensus and Training Programs.
    Ann Surg Oncol. 2023;30:5320-5322.
    >> Share

  120. KUNITOMO A, Ouchi A, Komori K, Kinoshita T, et al
    Clinical Impact of Radical Resection of Synchronous and Metachronous Peritoneal Metastases from Colorectal Cancer.
    Ann Surg Oncol. 2023 Sep 1. doi: 10.1245/s10434-023-14191.
    >> Share

    August 2023
  121. ZMUC J, Heil J, Herfarth C, Bechstein WO, et al
    Chemotherapy and Targeted Therapy Strategies in Patients with Unresectable or Borderline Resectable Metastatic Colorectal Cancer: Evidence for a Lack of Focus on Resection Rates.
    Ann Surg Oncol. 2023 Aug 30. doi: 10.1245/s10434-023-14049.
    >> Share

  122. YANG S, Jang H, Park IK, Lee HS, et al
    ASO Visual Abstract: Machine Learning Algorithms Using Systemic Inflammatory Markers for Predicting the Oncological Outcomes of Colorectal Cancer After Surgery.
    Ann Surg Oncol. 2023 Aug 29. doi: 10.1245/s10434-023-14234.
    >> Share

  123. KHALED C, El Asmar A, Liberale G
    Authors' Response to the Letter to the Editor "Prognostic Value of Preoperative Serological Biomarkers in Patients Undergoing Curative-Intent Cytoreductive Surgery for Colorectal Cancer Peritoneal Metastases".
    Ann Surg Oncol. 2023 Aug 24. doi: 10.1245/s10434-023-14196.
    >> Share

  124. WU H, Wang S, Lv H, Lou F, et al
    Effect of Thoracic Epidural Anesthesia on Perioperative Neutrophil Extracellular Trapping Markers in Patients Undergoing Anesthesia and Surgery for Colorectal Cancer: A Randomized, Controlled Trial.
    Ann Surg Oncol. 2023 Aug 22. doi: 10.1245/s10434-023-14077.
    >> Share

  125. YANG S, Jang H, Park IK, Lee HS, et al
    Machine-Learning Algorithms Using Systemic Inflammatory Markers to Predict the Oncologic Outcomes of Colorectal Cancer After Surgery.
    Ann Surg Oncol. 2023 Aug 21. doi: 10.1245/s10434-023-14136.
    >> Share

  126. YU J, Bai Y, Jin L, Zhang Z, et al
    A Prospective Long-Term Follow-Up Study: The Application of Circulating Tumor Cells Analysis to Guide Adjuvant Therapy in Stage II Colorectal Cancer.
    Ann Surg Oncol. 2023 Aug 19. doi: 10.1245/s10434-023-14168.
    >> Share

  127. ZWART K, van der Baan FH, Punt CJA, Wensink GE, et al
    ASO Visual Abstract: Survival of Patients with Deficient Mismatch Repair Versus Proficient Mismatch Repair Metastatic Colorectal Cancer Receiving Curative-Intent Local Treatment of Metastases in a Nationwide Cohort.
    Ann Surg Oncol. 2023 Aug 14. doi: 10.1245/s10434-023-14118.
    >> Share

  128. KANG J
    ASO Author Reflections: Could the Application of Machine Learning Enhance the Accuracy of Prognosis Estimation Using Serum Inflammatory Markers in Colorectal Cancer Patients?
    Ann Surg Oncol. 2023 Aug 14. doi: 10.1245/s10434-023-14154.
    >> Share

  129. WU H, Wang S, Lv H, Lou F, et al
    ASO Author Reflections: Can Anesthesia Techniques Affect Neutrophil Extracellular Trapping Expression in Patients during Colorectal Cancer Surgery?
    Ann Surg Oncol. 2023 Aug 14. doi: 10.1245/s10434-023-14150.
    >> Share

  130. ZWART K, Roodhart J
    ASO Author Reflections: Clinical Outcome After Upfront Curative-Intent Local Treatment of Metastases in Patient with Deficient Mismatch Repair Versus Proficient Mismatch Repair Metastatic Colorectal Cancer.
    Ann Surg Oncol. 2023 Aug 10. doi: 10.1245/s10434-023-14069.
    >> Share

  131. GIANNONE F, Grollemund A, Schuster C, Pessaux P, et al
    ASO Author Reflections: Oncological Safety of Radiofrequency Ablation in Colorectal Metastases.
    Ann Surg Oncol. 2023;30:4867-4868.
    >> Share

  132. HILL AL, Cullinan DR, Ahmed O, Vachharajani N, et al
    ASO Visual Abstract: Liver Transplant After Hepatic Artery Infusion Pump Therapy: Single-Center Experience and Technical Considerations.
    Ann Surg Oncol. 2023;30:4781-4782.
    >> Share

  133. SHARON CE, Wang M, Tortorello GN, Perry NJ, et al
    ASO Visual Abstract: Impact of Patient Comorbidities on Presentation Stage of Breast and Colon Cancers.
    Ann Surg Oncol. 2023;30:4629-4630.
    >> Share

  134. AL-SUKHNI E, Shapiro J, Suraweera H, Semotiuk K, et al
    Desmoid Tumors in Familial Adenomatous Polyposis Patients: Favorable Outcomes with Multidisciplinary Management.
    Ann Surg Oncol. 2023;30:5142-5149.
    >> Share

  135. WANG XY, Chen JH
    ASO Author Refections: Early ctDNA Dynamics Outperform Conventional Tumor Markers in Predicting Neoadjuvant Therapy Response and Recurrence in Colorectal Liver Metastases.
    Ann Surg Oncol. 2023;30:5264-5265.
    >> Share

  136. LIU W, Jin KM, Zhang MH, Bao Q, et al
    Recurrence Prediction by Circulating Tumor DNA in the Patient with Colorectal Liver Metastases After Hepatectomy: A Prospective Biomarker Study.
    Ann Surg Oncol. 2023;30:4916-4926.
    >> Share

  137. WANG XY, Zhang R, Han JH, Chen SQ, et al
    ASO Visual Abstract: Early Circulating Tumor DNA Dynamics Predict Neoadjuvant Therapy Response and Recurrence in Colorectal Liver Metastases-A Prospective Study.
    Ann Surg Oncol. 2023;30:5266.
    >> Share

  138. KARIM A, Freeman MJ, Yang Q, Leverson G, et al
    ASO Visual Abstract: Duration of Time CD4/CD8 Ratio is Below 0.5 is Associated with Progression to Anal Cancer in Patients with HIV and High-Grade Dysplasia.
    Ann Surg Oncol. 2023;30:4746-4747.
    >> Share

  139. SHARON CE, Wang M, Tortorello GN, Perry NJ, et al
    Impact of Patient Comorbidities on Presentation Stage of Breast and Colon Cancers.
    Ann Surg Oncol. 2023;30:4617-4626.
    >> Share

  140. WANG XY, Zhang R, Han JH, Chen SQ, et al
    Early Circulating Tumor DNA Dynamics Predict Neoadjuvant Therapy Response and Recurrence in Colorectal Liver Metastases: A Prospective Study.
    Ann Surg Oncol. 2023;30:5252-5263.
    >> Share

  141. GIANNONE F, Grollemund A, Felli E, Mayer T, et al
    ASO Visual Abstract: Combining Radiofrequency Ablation with Hepatic Resection for Liver-Only Colo-rectal Metastases: A Propensity-Score-Based Analysis on Long-Term Outcomes.
    Ann Surg Oncol. 2023;30:4869-4870.
    >> Share

  142. GIANNONE F, Grollemund A, Felli E, Mayer T, et al
    Combining Radiofrequency Ablation with Hepatic Resection for Liver-Only Colorectal Metastases: A Propensity-Score Based Analysis of Long-Term Outcomes.
    Ann Surg Oncol. 2023;30:4856-4866.
    >> Share

  143. HODGES N, Battersby N, Rao S, Brown G, et al
    ASO Visual Abstract: The Relationship Between Baseline Rectal Tumour Length and Magnetic Resonance Tumour Regression Grade (mrTRG) Response to Chemoradiotherapy-A Sub-analysis of the Trigger Feasibility Study.
    Ann Surg Oncol. 2023;30:4736.
    >> Share

  144. SHARON CE, Miura JT, Karakousis GC
    ASO Author Reflections: Evaluating the Relationship Between Patient Comorbidities and Stage at Diagnosis for Breast and Colon Cancers.
    Ann Surg Oncol. 2023;30:4627-4628.
    >> Share

  145. PEREZ RO, Sao Juliao GP
    Rectal Cancer Management and the Long List of Unanswered Questions.
    Ann Surg Oncol. 2023;30:4566-4567.
    >> Share

  146. YAMAGUCHI T, Akiyoshi T, Fukunaga Y, Sakamoto T, et al
    ASO Visual Abstract: Adding Induction Chemotherapy Before Chemoradiotherapy with Total Mesorectal Excision and Selective Lateral Lymph Node Dissection in Patients with Poor-Risk, Locally Advanced, Mid-to-Low Rectal Cancer May Improve Oncological Outco
    Ann Surg Oncol. 2023;30:4727-4728.
    >> Share

  147. YAMAGUCHI T, Akiyoshi T, Konishi T
    ASO Author Reflections: Oncological Outcomes of Adding Induction Chemotherapy Before Chemoradiotherapy with Total Mesorectal Excision and Selective Lateral Lymph Node Dissection in Patients with Poor-Risk, Locally Advanced Rectal Cancer.
    Ann Surg Oncol. 2023;30:4725-4726.
    >> Share

  148. YAMAGUCHI T, Akiyoshi T, Fukunaga Y, Sakamoto T, et al
    Adding Induction Chemotherapy Before Chemoradiotherapy with Total Mesorectal Excision and Selective Lateral Lymph Node Dissection for Patients with Poor-Risk, Locally Advanced, Mid-to-Low Rectal Cancer May Improve Oncologic Outcomes: A Propensity Scor
    Ann Surg Oncol. 2023;30:4716-4724.
    >> Share

  149. SANGER CB, Striker R
    ASO Author Reflections: Using Objective Markers to Tailor Frequency of Anal Dysplasia Treatments in People Living with HIV.
    Ann Surg Oncol. 2023;30:4744-4745.
    >> Share

  150. KARIM A, Freeman MJ, Yang Q, Leverson G, et al
    Duration of Time CD4/CD8 Ratio is Below 0.5 is Associated with Progression to Anal Cancer in Patients with HIV and High-Grade Dysplasia.
    Ann Surg Oncol. 2023;30:4737-4743.
    >> Share

  151. HODGES N, Battersby N, Rao S, Brown G, et al
    Relationship Between Baseline Rectal Tumor Length and Magnetic Resonance Tumor Regression Grade Response to Chemoradiotherapy: A Subanalysis of the TRIGGER Feasibility Study.
    Ann Surg Oncol. 2023;30:4729-4735.
    >> Share

  152. ZWART K, van der Baan FH, Punt CJA, Wensink GE, et al
    Survival of Patients with Deficient Mismatch Repair Versus Proficient Mismatch Repair Metastatic Colorectal Cancer Receiving Curative-Intent Local Treatment of Metastases in a Nationwide Cohort.
    Ann Surg Oncol. 2023 Aug 1. doi: 10.1245/s10434-023-13974.
    >> Share

    July 2023
  153. HAKKI L, Khan A, Ehrich F, Thompson HM, et al
    ASO Visual Abstract: Younger Patients with Colon Cancer are More Likely to Experience Financial Toxicity Than Older Patients.
    Ann Surg Oncol. 2023 Jul 30. doi: 10.1245/s10434-023-14018.
    >> Share

  154. HAKKI L, Khan A, Ehrich F, Thompson HM, et al
    Younger Patients with Colon Cancer are More Likely to Experience Financial Toxicity Than Older Patients.
    Ann Surg Oncol. 2023 Jul 21. doi: 10.1245/s10434-023-13911.
    >> Share

  155. SUMIYOSHI S, Shiozaki A, Kosuga T, Simizu H, et al
    ASO Visual Abstract: Functional Analysis and Clinical Importance of ATP1A1 in Colon Cancer.
    Ann Surg Oncol. 2023 Jul 20. doi: 10.1245/s10434-023-13915.
    >> Share

  156. RINER AN, Sharp SP
    ASO Author Reflections: Identifying Racial Disparities for Minimally Invasive Approaches to the Surgical Treatment of Colorectal Cancer.
    Ann Surg Oncol. 2023 Jul 15. doi: 10.1245/s10434-023-13742.
    >> Share

  157. ZOU M, Li PH, Yang ZQ, Gao F, et al
    Letter to the Editor "Prognostic Value of Preoperative Serological Biomarkers in Patients Undergoing Curative Intent Cytoreductive Surgery for Colorectal Cancer Peritoneal Metastases".
    Ann Surg Oncol. 2023 Jul 15. doi: 10.1245/s10434-023-13917.
    >> Share

  158. RINER AN, Herremans KM, Deng X, Bandyopadhyay D, et al
    ASO Visual Abstract: Racial/Ethnic Disparities in the Era of Minimally Invasive Surgery for Treatment of Colorectal Cancer.
    Ann Surg Oncol. 2023 Jul 15. doi: 10.1245/s10434-023-13828.
    >> Share

  159. RINER AN, Herremans KM, Deng X, Bandyopadhyay D, et al
    Racial/Ethnic Disparities in the Era of Minimally Invasive Surgery for Treatment of Colorectal Cancer.
    Ann Surg Oncol. 2023 Jul 9. doi: 10.1245/s10434-023-13693.
    >> Share

  160. SUMIYOSHI S, Shiozaki A, Kosuga T, Simizu H, et al
    Functional Analysis and Clinical Importance of ATP1A1 in Colon Cancer.
    Ann Surg Oncol. 2023 Jul 5. doi: 10.1245/s10434-023-13779.
    >> Share

  161. HAMED AB, Shuai Y, Derby J, Holtzman MP, et al
    ASO Visual Abstract: Impact of Primary Tumor Location and Genomic Alterations on Survival Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion for Colorectal Peritoneal Metastases.
    Ann Surg Oncol. 2023;30:4473-4474.
    >> Share

  162. THOMPSON HM, Widmar M
    ASO Author Reflections: Understanding the Association between Extramural Venous Invasion and Survival in Rectal Cancer Patients.
    Ann Surg Oncol. 2023;30:3966.
    >> Share

  163. HIYOSHI Y, Daitoku N, Mukai T, Nagasaki T, et al
    ASO Visual Abstract: Risk Factors for Lymph Node Metastasis of Rectal Neuroendocrine Tumor and its Prognostic Impact-A Single-Center Retrospective Analysis of 195 Cases with Radical Resection.
    Ann Surg Oncol. 2023;30:3956.
    >> Share

  164. HAMED AB, Choudry MH
    ASO Author Reflections: Significance of Primary Tumor Location and Genomic Alterations in Colorectal Peritoneal Metastases and Cytoreductive Surgery-Hyperthermic Intraperitoneal Chemotherapy.
    Ann Surg Oncol. 2023;30:4471-4472.
    >> Share

  165. THOMPSON HM, Bates DDB, Pernicka JG, Park SJ, et al
    ASO Visual Abstract: MRI Assessment of Extramural Venous Invasion Before and After Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer and its Association with Disease-Free and Overall Survival.
    Ann Surg Oncol. 2023;30:3967-3968.
    >> Share

  166. HAMED AB, Shuai Y, Derby J, Holtzman MP, et al
    Impact of Primary Tumor Location and Genomic Alterations on Survival Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion for Colorectal Peritoneal Metastases.
    Ann Surg Oncol. 2023;30:4459-4470.
    >> Share

  167. MCKIGNEY NA, Houston F, Ross E, Velikova G, et al
    ASO Author Reflections: What is the Quality of Reporting Patient-Reported Outcome Measures in Locally Recurrent Rectal Cancer?
    Ann Surg Oncol. 2023;30:3987-3988.
    >> Share

  168. MCKIGNEY N, Houston F, Ross E, Velikova G, et al
    Systematic Review of Patient-Reported Outcome Measures in Locally Recurrent Rectal Cancer.
    Ann Surg Oncol. 2023;30:3969-3986.
    >> Share

  169. SOLSKY I, Moaven O, Valenzuela CD, Lundy M, et al
    ASO Visual Abstract: Survival Outcomes of Optimally Treated Colorectal Metastases-The Importance of R0 Status in Surgical Treatment of Hepatic and Peritoneal Surface Disease.
    Ann Surg Oncol. 2023;30:4274-4275.
    >> Share

  170. THOMPSON HM, Bates DDB, Pernicka JG, Park SJ, et al
    MRI Assessment of Extramural Venous Invasion Before and After Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer and Its Association with Disease-Free and Overall Survival.
    Ann Surg Oncol. 2023;30:3957-3965.
    >> Share

  171. HIYOSHI Y, Daitoku N, Mukai T, Nagasaki T, et al
    Risk Factors for Lymph Node Metastasis of Rectal Neuroendocrine Tumor and Its Prognostic Impact: A Single-Center Retrospective Analysis of 195 Cases with Radical Resection.
    Ann Surg Oncol. 2023;30:3944-3953.
    >> Share

  172. SWARTJES H, van Rees JM, van Erning FN, Verheij M, et al
    ASO Visual Abstract: Locally Recurrent Rectal Cancer: Toward a Second Chance at Cure? A Population-Based, Retrospective, Cohort Study.
    Ann Surg Oncol. 2023;30:3927-3928.
    >> Share

  173. HIYOSHI Y, Mukai T, Nagasaki T, Yamaguchi T, et al
    ASO Author Reflections: Rectal Neuroendocrine Tumors Have Strong Potential for Lymph Node Metastasis in Accordance with an Increase of Risk Factors, and Lymph Node Metastasis is Associated with a Poor Prognosis.
    Ann Surg Oncol. 2023;30:3954-3955.
    >> Share

  174. SCHELL F, Kefleyesus A, Benzerdjeb N, Passot G, et al
    ASO Visual Abstract: Influence of Extraperitoneal Metastases on the Curative-Intent Management of Colorectal Peritoneal Metastases.
    Ann Surg Oncol. 2023;30:4457-4458.
    >> Share

  175. SCHELL F, Kefleyesus A, Benzerdjeb N, Passot G, et al
    Influence of Extraperitoneal Metastases on the Curative-Intent Management of Colorectal Peritoneal Metastases.
    Ann Surg Oncol. 2023;30:4444-4454.
    >> Share

  176. SWARTJES H, van Rees JM, van Erning FN, Verheij M, et al
    Locally Recurrent Rectal Cancer: Toward a Second Chance at Cure? A Population-Based, Retrospective Cohort Study.
    Ann Surg Oncol. 2023;30:3915-3924.
    >> Share

  177. SWARTJES H, Koeter T
    ASO Author Reflections: Locally Recurrent Rectal Cancer from a Nationwide Perspective.
    Ann Surg Oncol. 2023;30:3925-3926.
    >> Share

  178. SOLSKY I, Moaven O, Valenzuela CD, Lundy M, et al
    Survival Outcomes of Optimally Treated Colorectal Metastases: The Importance of R0 Status in Surgical Treatment of Hepatic and Peritoneal Surface Disease.
    Ann Surg Oncol. 2023;30:4264-4273.
    >> Share

    June 2023
  179. SUMIYOSHI S, Shiozaki A, Otsuji E
    ASO Author Reflections: Expression and Role of ATP1A1 in Colon Cancer.
    Ann Surg Oncol. 2023 Jun 21. doi: 10.1245/s10434-023-13790.
    >> Share

  180. JAIN B, Bajaj SS, Patel TA, Vapiwala N, et al
    ASO Visual Abstract: Colon Cancer Disparities in Stage at Presentation and Time to Surgery for Asian Americans, Native Hawaiians, and Pacific Islanders: A Study with Disaggregated Ethnic Groups.
    Ann Surg Oncol. 2023 Jun 17. doi: 10.1245/s10434-023-13699.
    >> Share

  181. GINESI MC, Bliggenstorfer JT, Kwesiga DM, Xu SH, et al
    ASO Visual Abstract: Factors Associated with Receipt of Adjuvant Chemotherapy in Stage II Colon Cancer.
    Ann Surg Oncol. 2023 Jun 16. doi: 10.1245/s10434-023-13705.
    >> Share

  182. TAGERMAN DL, In H
    ASO Author Reflections: Potentially Avoidable and Prolonged Hospitalizations for Suspected Colon Cancer-Hospital Impact.
    Ann Surg Oncol. 2023 Jun 3. doi: 10.1245/s10434-023-13648.
    >> Share

  183. SHINTO E, Oki E, Shimokawa M, Yamaguchi S, et al
    ASO Visual Abstract: Enhanced Clinical Utility of Molecular Budding Signature as a Recurrence Risk Determinant in Stage II and III Colon Cancer Patients.
    Ann Surg Oncol. 2023 Jun 2. doi: 10.1245/s10434-023-13684.
    >> Share

  184. HARPAIN F, Dawoud C, Wimmer K, Schlager L, et al
    ASO Visual Abstract: Fistula-Associated Anal Adenocarcinoma: A 20-Year Single-Center Experience.
    Ann Surg Oncol. 2023;30:3528-3529.
    >> Share

  185. CONCORS S, Haddad A, Vauthey JN
    Modeling the Prediction of Early Treatment Failure After Hepatectomy for Colorectal Liver Metastases.
    Ann Surg Oncol. 2023;30:3182-3183.
    >> Share

  186. VALENZUELA CD, Moaven O, Solsky IB, Stauffer JA, et al
    ASO Visual Abstract: Conditional Survival After Hepatectomy for Colorectal Liver Metastasis-Results from the Colorectal Liver Operative Metastasis International Collaborative (COLOMIC).
    Ann Surg Oncol. 2023;30:3423-3424.
    >> Share

  187. DUMONT F, Kepenekian V, De Franco V, Eveno C, et al
    Delaying Surgery After Neoadjuvant Chemotherapy Affects Survival in Patients with Colorectal Peritoneal Metastases: A BIG-RENAPE Network Multicentric Study.
    Ann Surg Oncol. 2023;30:3549-3559.
    >> Share

  188. EL ASMAR A, Demetter P, Fares F, Sclafani F, et al
    ASO Visual Abstract: The Prognostic Value of Distinct Histological Growth Patterns of Colorectal Peritoneal Metastases-A Pilot Study.
    Ann Surg Oncol. 2023;30:3331-3332.
    >> Share

  189. VALENZUELA CD, Moaven O, Solsky IB, Stauffer JA, et al
    Conditional Survival After Hepatectomy for Colorectal Liver Metastasis: Results from the Colorectal Liver Operative Metastasis International Collaborative (COLOMIC).
    Ann Surg Oncol. 2023;30:3413-3422.
    >> Share

  190. RIVARD SJ, Vitous CA, Bamdad MC, Lussiez A, et al
    "I Wish There had been Resources": A Photo-Elicitation Study of Rectal Cancer Survivorship Care Needs.
    Ann Surg Oncol. 2023;30:3530-3537.
    >> Share

  191. KAWAGUCHI Y, Jain AJ, Chun YS, Vauthey JN, et al
    Artificial Intelligence or Tumor Biology to Predict Survival After Resection of Colorectal Liver Metastases?
    Ann Surg Oncol. 2023;30:3161-3162.
    >> Share

  192. HARPAIN F, Dawoud C, Wimmer K, Schlager L, et al
    Fistula-Associated Anal Adenocarcinoma: A 20-Year Single-Center Experience.
    Ann Surg Oncol. 2023;30:3517-3527.
    >> Share

  193. EL ASMAR A, Demetter P, Fares F, Sclafani F, et al
    The Prognostic Value of Distinct Histological Growth Patterns of Colorectal Peritoneal Metastases: A Pilot Study.
    Ann Surg Oncol. 2023;30:3320-3328.
    >> Share

  194. EL ASMAR A, Liberale G
    ASO Author Reflections: Peritoneal Metastases of Colorectal Origin Exhibit Distinct Histological Growth Patterns with a Potential Prognostic Value.
    Ann Surg Oncol. 2023;30:3329-3330.
    >> Share

  195. NAKANISHI R, Morooka K, Omori K, Toyota S, et al
    ASO Visual Abstract: Artificial Intelligence-Based Prediction of Recurrence After Curative Resection for Colorectal Cancer From a Digital Pathologic Image.
    Ann Surg Oncol. 2023;30:3515-3516.
    >> Share

  196. WONG GYM, Diakos C, Molloy MP, Hugh TJ, et al
    Current Challenges in Defining Futile Liver Resection and Predicting Early Recurrence After Curative-Intent Treatment for Colorectal Liver Metastases.
    Ann Surg Oncol. 2023;30:3425-3426.
    >> Share

    May 2023
  197. BOND MJG, Kuiper BI, Bolhuis K, Komurcu A, et al
    ASO Visual Abstract: Intersurgeon Variability in Local Treatment Planning for Patients with Initially Unresectable Colorectal Cancer Liver Metastases-Analysis of the Liver Expert Panel of the Dutch Colorectal Cancer Group.
    Ann Surg Oncol. 2023 May 30. doi: 10.1245/s10434-023-13595.
    >> Share

  198. GINESI MC, Bliggenstorfer JT, Kwesiga DM, Xu SH, et al
    Factors Associated with Receipt of Adjuvant Chemotherapy in Stage II Colon Cancer.
    Ann Surg Oncol. 2023 May 30. doi: 10.1245/s10434-023-13631.
    >> Share

  199. YAMAMOTO T, Tsunedomi R, Nakajima M, Suzuki N, et al
    IL-6 Levels Correlate with Prognosis and Immunosuppressive Stromal Cells in Patients with Colorectal Cancer.
    Ann Surg Oncol. 2023 May 24. doi: 10.1245/s10434-023-13527.
    >> Share

  200. TAGERMAN DL, Ramos-Santillan V, Kalam A, Wang F, et al
    Potentially Avoidable Admissions and Prolonged Hospitalization in Patients with Suspected Colon Cancer.
    Ann Surg Oncol. 2023 May 17. doi: 10.1245/s10434-023-13593.
    >> Share

  201. YAMAMOTO T, Tsunedomi R, Nakajima M, Suzuki N, et al
    ASO Visual Abstract: Interleukin-6 Levels Correlate with Prognosis and Immunosuppressive Stromal Cells in Patients with Colorectal Cancer.
    Ann Surg Oncol. 2023 May 17. doi: 10.1245/s10434-023-13644.
    >> Share

  202. SHINTO E, Oki E, Shimokawa M, Yamaguchi S, et al
    Enhanced Clinical Utility of Molecular Budding Signature as a Recurrence Risk Determinant in Stage II and III Colon Cancer Patients.
    Ann Surg Oncol. 2023 May 8. doi: 10.1245/s10434-023-13594.
    >> Share

  203. YAMAMOTO T, Tsunedomi R, Nakajima M, Nagano H, et al
    ASO Author Reflections: Characteristics of the Relationship Between IL-6 Levels and Tumor Microenvironment in Patients with Colorectal Cancer.
    Ann Surg Oncol. 2023 May 5. doi: 10.1245/s10434-023-13578.
    >> Share

  204. PROCOPIO F, Branciforte B, Torzilli G
    ASO Author Reflections: Moving Toward the Future: Minimal Access R1 Vascular Surgery for Colorectal Liver Metastases at the Caval Confluence.
    Ann Surg Oncol. 2023;30:2837-2838.
    >> Share

  205. SASAKI K, Ruffolo LI, Kim MH, Fujiki M, et al
    ASO Visual Abstract: The Current State of Liver Transplantation for Colorectal Liver Metastases in the United States: A Call for Standardized Reporting.
    Ann Surg Oncol. 2023;30:2780-2781.
    >> Share

  206. DOKMAK S, Lesurtel M
    ASO Author Reflections: Surgical Strategy for Bilobar Colorectal Liver Metastases with Vascular Invasion.
    Ann Surg Oncol. 2023;30:2841-2842.
    >> Share

  207. BERARDI G, Chou J, Gonen M, Balachandran VP, et al
    ASO Visual Abstract: A Model to Predict Treatment Failure in Patients Undergoing Upfront Surgery for Resectable Colorectal Liver Metastases.
    Ann Surg Oncol. 2023;30:2830-2831.
    >> Share

  208. BAKKERS C, Rovers KP, Rijken A, Simkens GAAM, et al
    Perioperative Systemic Therapy Versus Cytoreductive Surgery and HIPEC Alone for Resectable Colorectal Peritoneal Metastases: Patient-Reported Outcomes of a Randomized Phase II Trial.
    Ann Surg Oncol. 2023;30:2678-2688.
    >> Share

  209. KANNO H, Hisaka T, Fujiyoshi K, Akiba J, et al
    ASO Visual Abstract: Prognostic Significance of the Histopathologic Growth Pattern and Tumor-Infiltrating Lymphocytes in Stratifying Survival After Hepatectomy for Colorectal Liver Metastases.
    Ann Surg Oncol. 2023;30:3149.
    >> Share

  210. ZINGG SW, Shah SA
    Where are We with Liver Transplant for Unresectable Colorectal Metastases? Its Early, but Some Initial Insights are Evident.
    Ann Surg Oncol. 2023;30:2584-2585.
    >> Share

  211. SASAKI K, Ruffolo LI, Kim MH, Fujiki M, et al
    The Current State of Liver Transplantation for Colorectal Liver Metastases in the United States: A Call for Standardized Reporting.
    Ann Surg Oncol. 2023;30:2769-2777.
    >> Share

  212. BOZHILOV K, Melcher ML, Hernandez-Alejandro R, Sasaki K, et al
    ASO Author Reflections: At the Crossroad-Liver Transplantation for Unresectable Colorectal Liver Metastases in the United States.
    Ann Surg Oncol. 2023;30:2778-2779.
    >> Share

  213. PROCOPIO F, Cimino M, Milana F, Franchi E, et al
    Laparoscopic Ultrasound-Guided R1 Vascular Liver Resection for Colorectal Liver Metastases at Caval Confluence.
    Ann Surg Oncol. 2023;30:2836.
    >> Share

  214. BERARDI G, D'Angelica M
    ASO Author Reflections: Upfront Surgery for Resectable Colorectal Liver Metastases: Biology is (Still) King.
    Ann Surg Oncol. 2023;30:2828-2829.
    >> Share

  215. BERARDI G, Chou J, Gonen M, Balachandran VP, et al
    A Model to Predict Treatment Failure in Patients Undergoing Upfront Surgery for Resectable Colorectal Liver Metastases.
    Ann Surg Oncol. 2023;30:2820-2827.
    >> Share

  216. GRAVERSEN M, Detlefsen S, Ainsworth AP, Fristrup CW, et al
    Treatment of Peritoneal Metastasis with Pressurized Intraperitoneal Aerosol Chemotherapy: Results from the Prospective PIPAC-OPC2 Study.
    Ann Surg Oncol. 2023;30:2634-2644.
    >> Share

  217. GEVA R, Alon G, Nathanson M, Bar-David S, et al
    PD-1 Blockade Combined with Heated Intraperitoneal Chemotherapy Improves Outcome in Experimental Peritoneal Metastases from Colonic Origin in a Murine Model.
    Ann Surg Oncol. 2023;30:2657-2663.
    >> Share

  218. KANNO H, Hisaka T
    ASO Author Reflections: A Combination of the Histopathologic Growth Pattern and Tumor-Infiltrating Lymphocytes Can Stratify the Risk in Survival After Hepatectomy for Colorectal Liver Metastasis.
    Ann Surg Oncol. 2023;30:3148.
    >> Share

  219. KANNO H, Hisaka T, Fujiyoshi K, Akiba J, et al
    Prognostic Significance of the Histopathological Growth Pattern and Tumor-Infiltrating Lymphocytes in Stratifying Survival After Hepatectomy for Colorectal Liver Metastases.
    Ann Surg Oncol. 2023;30:3139-3147.
    >> Share

  220. JASTRZEBSKI T
    Unreliability in the Treatment of Patients with Peritoneal Metastases of Colorectal Cancer in the Current NCCN and ASCO Recommendations.
    Ann Surg Oncol. 2023 May 1. doi: 10.1245/s10434-023-13576.
    >> Share

    April 2023
  221. JAIN B, Bajaj SS, Patel TA, Vapiwala N, et al
    ASO Author Reflections: Colon Cancer Disparities in Stage at Presentation and Time to Surgery for Asian Americans, Native Hawaiians, and Pacific Islanders.
    Ann Surg Oncol. 2023 Apr 29. doi: 10.1245/s10434-023-13560.
    >> Share

  222. BOND MJG, Kuiper BI, Bolhuis K, Komurcu A, et al
    Intersurgeon Variability in Local Treatment Planning for Patients with Initially Unresectable Colorectal Cancer Liver Metastases: Analysis of the Liver Expert Panel of the Dutch Colorectal Cancer Group.
    Ann Surg Oncol. 2023 Apr 28. doi: 10.1245/s10434-023-13510.
    >> Share

  223. BOND MJG, Punt CJA, Swijnenburg RJ
    ASO Author Reflections: Towards Consensus on Resectability Assessments and Local Treatment Planning for Patients with Initially Unresectable Colorectal Cancer Liver Metastases.
    Ann Surg Oncol. 2023 Apr 21. doi: 10.1245/s10434-023-13513.
    >> Share

  224. CHILDERS CP, Uppal A, Tillman M, Chang GJ, et al
    ASO Visual Abstract: Insurance Disparities in Access to Robotic Surgery for Colorectal Cancer.
    Ann Surg Oncol. 2023 Apr 13. doi: 10.1245/s10434-023-13454.
    >> Share

  225. KOZMAN MA, Fisher OM, Liauw W, Morris DL, et al
    Use of Prognostic Factors and Scores in Selection of Patients with Colorectal Cancer Peritoneal Metastasis (CRPM) for Cytoreductive Surgery and Intraperitoneal Chemotherapy (CRS/IPC): Results of an International Survey Among Oncologic Clinicians.
    Ann Surg Oncol. 2023 Apr 5. doi: 10.1245/s10434-022-12794.
    >> Share

  226. JAIN B, Bajaj SS, Patel TA, Vapiwala N, et al
    Colon Cancer Disparities in Stage at Presentation and Time to Surgery for Asian Americans, Native Hawaiians, and Pacific Islanders: A Study with Disaggregated Ethnic Groups.
    Ann Surg Oncol. 2023 Apr 5:1-11. doi: 10.1245/s10434-023-13339.
    >> Share

  227. WEI AC
    Practice-Changing Evidence in Surgical Oncology 2021: Hepatobiliary Articles.
    Ann Surg Oncol. 2023;30:1960-1965.
    >> Share

  228. DIETZ MV, Ziekman MJ, van Kooten JP, Brandt-Kerkhof ARM, et al
    ASO Visual Abstract: Treatment and Survival Outcomes of Patients with Colorectal Peritoneal Metastases Deemed Ineligible for Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Results of a Retrospective Study.
    Ann Surg Oncol. 2023;30:2057.
    >> Share

  229. NIKIFORCHIN A, Sardi A, King MC, Baron E, et al
    ASO Visual Abstract: Safety of Nephrectomy Performed During CRS/HIPEC-A Propensity Score-Matched Study.
    Ann Surg Oncol. 2023;30:2531.
    >> Share

  230. DIETZ MV, Ziekman MJ, van Kooten JP, Brandt-Kerkhof ARM, et al
    Treatment and Survival Outcomes for Patients with Colorectal Peritoneal Metastases Deemed Ineligible for Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Results of a Retrospective Study.
    Ann Surg Oncol. 2023;30:2048-2056.
    >> Share

  231. MANGIERI CW, Valenzuela CD, Solsky IB, Erali RA, et al
    Exposure to Neoadjuvant Oxaliplatin-Containing Chemotherapy, Does it Effect Intraperitoneal Hyperthermic Chemotherapy Perfusion?
    Ann Surg Oncol. 2023;30:2486-2493.
    >> Share

    March 2023
  232. HONAKER MD, Irish W, Parikh AA, Snyder RA, et al
    ASO Author Reflections: Rural-Urban Disparities in Colon Cancer Care: Trying to Close the Gap.
    Ann Surg Oncol. 2023 Mar 31. doi: 10.1245/s10434-023-13381.
    >> Share

  233. KOZMAN MA, Fisher OM, Liauw W, Morris DL, et al
    ASO Visual Abstract: Use of Prognostic Factors and Scores in Selection of Patients with Colorectal Cancer Peritoneal Metastasis (CRPM) for Cytoreductive Surgery and Intraperitoneal Chemotherapy (CRS/IPC): Results of an International Survey Among Oncol
    Ann Surg Oncol. 2023 Mar 30. doi: 10.1245/s10434-022-12857.
    >> Share

  234. HONAKER MD, Irish W, Parikh AA, Snyder RA, et al
    ASO Visual Abstract: Association of Rural Residence and Receipt of Guideline Concordant Care for Locoregional Colon Cancer.
    Ann Surg Oncol. 2023 Mar 30. doi: 10.1245/s10434-023-13403.
    >> Share

  235. CHILDERS CP, Uppal A, Tillman M, Chang GJ, et al
    Insurance Disparities in Access to Robotic Surgery for Colorectal Cancer.
    Ann Surg Oncol. 2023 Mar 21. doi: 10.1245/s10434-023-13354.
    >> Share

  236. HONAKER MD, Irish W, Parikh AA, Snyder RA, et al
    Association of Rural Residence and Receipt of Guideline-Concordant Care for Locoregional Colon Cancer.
    Ann Surg Oncol. 2023 Mar 18. doi: 10.1245/s10434-023-13340.
    >> Share

  237. VALLEJOS PA, Gonda A, Yu J, Sullivan BG, et al
    ASO Visual Abstract: Plasma Exosome Gene Signature Differentiates Colon Cancer from Healthy Controls.
    Ann Surg Oncol. 2023 Mar 16. doi: 10.1245/s10434-023-13303.
    >> Share

  238. KEPENEKIAN V, Kefleyesus A, Passot G, Rousset P, et al
    ASO Author Reflections: Colorectal Cancer Patients with Peritoneal Metastases and Other Metastatic Sites Can Benefit from Radical Multifocal Treatment After Comprehensive Evaluation for Accurate Selection.
    Ann Surg Oncol. 2023 Mar 12. doi: 10.1245/s10434-023-13320.
    >> Share

  239. FANGET F, Kefleyesus A, Peron J, Bonnefoy I, et al
    ASO Visual Abstract: Comparison of Neoadjuvant Systemic Chemotherapy Protocols for the Curative-Intent Management of Peritoneal Metastases from Colorectal Cancer, Regarding Morphological Response, Pathological Response, and Long-Term Outcomes - A Retr
    Ann Surg Oncol. 2023 Mar 7. doi: 10.1245/s10434-023-13300.
    >> Share

  240. VALLEJOS PA, Gonda A, Yu J, Sullivan BG, et al
    Plasma Exosome Gene Signature Differentiates Colon Cancer from Healthy Controls.
    Ann Surg Oncol. 2023 Mar 2. doi: 10.1245/s10434-023-13219.
    >> Share

  241. HANY TS, Jadav AM, Bhowmick AK
    ASO Visual Abstract: The Extra-Peritoneal Approach to Left-Sided Colorectal Rectal Resections-EXPERTS Procedure.
    Ann Surg Oncol. 2023;30:1742-1743.
    >> Share

  242. HANY TS, Jadav AM, Lamoon C, Cassidy K, et al
    The Extraperitoneal Approach to Left-Sided Colorectal Rectal Resections: EXPERTS Procedure.
    Ann Surg Oncol. 2023;30:1739-1740.
    >> Share

  243. SINNAMON AJ, Luo E, Xu A, Zhu S, et al
    Simultaneous Hepatic and Visceral Resection: Preoperative Risk Stratification and Implications on Return to Intended Oncologic Therapy.
    Ann Surg Oncol. 2023;30:1772-1783.
    >> Share

  244. BEAL EW, Srinivas S, Shen C, Kim A, et al
    Conditional Survival Following Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Surface Malignancies: An Analysis from the US HIPEC Collaborative.
    Ann Surg Oncol. 2023;30:1840-1849.
    >> Share

    February 2023
  245. ALON G, Geva R, Lahat G, Nizri E, et al
    ASO Author Reflections: HIPEC Immunogenic Changes Could be Further Exploited by Immunotherapy to Treat Peritoneal Metastases from Colorectal Cancer.
    Ann Surg Oncol. 2023 Feb 17. doi: 10.1245/s10434-023-13254.
    >> Share

  246. KEPENEKIAN V, Kefleyesus A, Passot G, Rousset P, et al
    ASO Author Reflections: Which is the Optimal Preoperative Systemic Chemotherapy Regimen for Patients with Peritoneal Metastases from Colorectal Cancer?
    Ann Surg Oncol. 2023 Feb 8. doi: 10.1245/s10434-023-13214.
    >> Share

  247. ABDELFATAH E, Ramos-Santillan V, Cherkassky L, Cianchetti K, et al
    ASO Visual Abstract: High Risk, High Reward: Frailty in Colorectal Cancer Surgery Associates with Worse Postoperative Outcomes But Equivalent Long-Term Oncologic Outcomes.
    Ann Surg Oncol. 2023 Feb 6. doi: 10.1245/s10434-022-13090.
    >> Share

  248. FANGET F, Kefleyesus A, Peron J, Bonnefoy I, et al
    Comparison of Neoadjuvant Systemic Chemotherapy Protocols for the Curative-Intent Management of Peritoneal Metastases from Colorectal Cancer, Regarding Morphological Response, Pathological Response, and Long-Term Outcomes: A Retrospective Study.
    Ann Surg Oncol. 2023 Feb 2. doi: 10.1245/s10434-023-13150.
    >> Share

  249. BHULLAR D, O'Dwyer S, Wilson M, Saunders MP, et al
    ASO Visual Abstract: RAS Mutation Status Should not be Used to Predict Outcome from Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases.
    Ann Surg Oncol. 2023;30:802-803.
    >> Share

  250. BHULLAR D, O'Dwyer S, Wilson M, Saunders MP, et al
    RAS Mutation Status Should Not Be Used to Predict Outcome from Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases.
    Ann Surg Oncol. 2023;30:792-801.
    >> Share

  251. CHOI M, Harper MM, Pandalai PK, Abdel-Misih SRZ, et al
    A Multicenter Phase 1 Trial Evaluating Nanoliposomal Irinotecan for Heated Intraperitoneal Chemotherapy Combined with Cytoreductive Surgery for Patients with Peritoneal Surface Disease.
    Ann Surg Oncol. 2023;30:804-813.
    >> Share

    January 2023
  252. HANEVELT J, Moons LMG, Hentzen JEKR, Wemeijer TM, et al
    ASO Visual Abstract: Colonoscopy-Assisted Laparoscopic Wedge Resection for the Treatment of Suspected T1 Colon Cancer.
    Ann Surg Oncol. 2023 Jan 21. doi: 10.1245/s10434-022-13070.
    >> Share

  253. HUANG E, Kalady MF
    45 is the New 50: Demographic Trends in Colorectal Cancer Drive Recent US Screening Guideline Changes.
    Ann Surg Oncol. 2023 Jan 19. doi: 10.1245/s10434-022-12986.
    >> Share

  254. ABDELFATAH E, Ramos-Santillan V, Cherkassky L, Cianchetti K, et al
    High Risk, High Reward: Frailty in Colorectal Cancer Surgery is Associated with Worse Postoperative Outcomes but Equivalent Long-Term Oncologic Outcomes.
    Ann Surg Oncol. 2023 Jan 17. doi: 10.1245/s10434-022-12970.
    >> Share

  255. JASTRZEBSKI T
    Colorectal Cancer T4: Should Prophylactic HIPEC be Performed? : Colorectal T4 HIPEC Prophylactic.
    Ann Surg Oncol. 2023 Jan 16. doi: 10.1245/s10434-023-13100.
    >> Share

  256. PEERENBOOM R, Dhiman A, Witmer HDD, Spurr LF, et al
    ASO Visual Abstract: PI3K Pathway Alterations in Peritoneal Metastases are Associated with Earlier Recurrence for Patients with Colorectal Cancer Undergoing Optimal Cytoreductive Surgery.
    Ann Surg Oncol. 2023 Jan 15. doi: 10.1245/s10434-022-12854.
    >> Share

  257. PEERENBOOM R, Dhiman A, Witmer HDD, Spurr LF, et al
    PI3K Pathway Alterations in Peritoneal Metastases are Associated with Earlier Recurrence in Patients with Colorectal Cancer Undergoing Optimal Cytoreductive Surgery.
    Ann Surg Oncol. 2023 Jan 13. doi: 10.1245/s10434-022-12784.
    >> Share

  258. HANEVELT J, Moons LMG, Hentzen JEKR, Wemeijer TM, et al
    Colonoscopy-Assisted Laparoscopic Wedge Resection for the Treatment of Suspected T1 Colon Cancer.
    Ann Surg Oncol. 2023 Jan 4. doi: 10.1245/s10434-022-12973.
    >> Share

  259. HANEVELT J, Moons LMG, de Vos Tot Nederveen Cappel WH, van Westreenen HL, et al
    ASO Author Reflections: Colonoscopic-Assisted Laparoscopic Wedge Resection Seems a Valuable Addition to the Current Local Resection Techniques in Case of Suspected Deep-Invasive T1 Colon Cancer.
    Ann Surg Oncol. 2023 Jan 4. doi: 10.1245/s10434-022-13051.
    >> Share

  260. RAMSAY R, Sampurno S, Flood MP, Lynch AC, et al
    ASO Author Reflections: Humidification of Carbon Dioxide for Insufflation Offers Promise in Reducing Inflammation and Peritoneal Trauma During and Post Colorectal Cancer Surgery.
    Ann Surg Oncol. 2023 Jan 2. doi: 10.1245/s10434-022-13014.
    >> Share

  261. KEILSON JM, Gamboa AC, Turgeon MK, Maguire L, et al
    Is There a Role for Adjuvant Chemotherapy in Pathologic Node-Negative Locally Advanced Rectal Cancer After Neoadjuvant Chemoradiation Therapy?
    Ann Surg Oncol. 2023;30:224-232.
    >> Share

  262. ARSHAD M, Al-Hallaq H, Polite BN, Shogan BD, et al
    Intra-operative Radiation Therapy for Colorectal or Anal Cancer at Risk for Margin-Positive Resection: Initial Results of a Single-Institution Registry.
    Ann Surg Oncol. 2023;30:325-332.
    >> Share

  263. ARSHAD M, Al-Hallaq H, Polite BN, Shogan BD, et al
    ASO Visual Abstract: Intraoperative Radiation Therapy for Colorectal or Anal Cancer at Risk for Margin-Positive Resection: Initial Results of a Single-Institution Registry.
    Ann Surg Oncol. 2023;30:333-334.
    >> Share

    December 2022
  264. SWARTJES H, van Lankveld DWP, van Erning FN, Verheul HMW, et al
    ASO Visual Abstract: Locoregionally Recurrent Colon Cancer: How Far Have We Come? A Population-Based, Retrospective Cohort Study.
    Ann Surg Oncol. 2022 Dec 19. doi: 10.1245/s10434-022-12782.
    >> Share

  265. NAKANISHI R, Morooka K, Omori K, Toyota S, et al
    Artificial Intelligence-Based Prediction of Recurrence after Curative Resection for Colorectal Cancer from Digital Pathological Images.
    Ann Surg Oncol. 2022 Dec 13. doi: 10.1245/s10434-022-12926.
    >> Share

  266. NEWTON AD, Newhook TE, Ikoma N, Tzeng CD, et al
    Robotic Extended Right Hepatectomy for Colorectal Liver Metastasis.
    Ann Surg Oncol. 2022;29:8455.
    >> Share

  267. MACHADO MAC, Mattos BV, Lobo Filho MM, Makdissi F, et al
    ASO Visual Abstract: Glissonian Approach During Robotic Mesohepatectomy for Recurrent Colorectal Liver Metastasis.
    Ann Surg Oncol. 2022;29:8454.
    >> Share

  268. KAWADA K, Itatani Y, Horie A, Yamanaka H, et al
    Robotic Posterior Exenteration for Locally Advanced Rectal Cancer with Rectovaginal Fistula.
    Ann Surg Oncol. 2022;29:8211-8212.
    >> Share

  269. MACHADO MAC, Mattos BV, Lobo Filho MM, Makdissi F, et al
    Glissonian Approach During Robotic Mesohepatectomy for Recurrent Colorectal Liver Metastasis.
    Ann Surg Oncol. 2022;29:8449-8451.
    >> Share

    November 2022
  270. EL ASMAR A, Delcourt M, Kamden L, Khaled C, et al
    ASO Visual Abstract: Prognostic Value of Preoperative Serological Biomarkers in Patients Undergoing Curative-Intent Cytoreductive Surgery for Colorectal Cancer Peritoneal Metastases.
    Ann Surg Oncol. 2022 Nov 19. doi: 10.1245/s10434-022-12817.
    >> Share

  271. EL ASMAR A, Delcourt M, Kamden L, Khaled C, et al
    Prognostic Value of Preoperative Serological Biomarkers in Patients Undergoing Curative-Intent Cytoreductive Surgery for Colorectal Cancer Peritoneal Metastases.
    Ann Surg Oncol. 2022 Nov 9. pii: 10.1245/s10434-022-12736.
    >> Share

  272. GRIFFITHS CD, Karanicolas P, Gallinger S, Wei AD, et al
    Health-Related Quality of Life Following Simultaneous Resection for Synchronous Colorectal Cancer Liver Metastases.
    Ann Surg Oncol. 2022 Nov 9. pii: 10.1245/s10434-022-12696.
    >> Share

  273. EL ASMAR A, Liberale G
    ASO Author Reflections: Preoperative Serological Biomarkers as Novel Prognostic Factors in Patients with Peritoneal Metastases of Colorectal Cancer Origin.
    Ann Surg Oncol. 2022 Nov 6. pii: 10.1245/s10434-022-12771.
    >> Share

  274. SWARTJES H, de Wilt H
    ASO Author Reflections: Real-World Conclusions on Locoregionally Recurrent Colon Cancer.
    Ann Surg Oncol. 2022 Nov 5. pii: 10.1245/s10434-022-12772.
    >> Share

  275. FLOOD MP, Kong JCH, Heriot AG
    Reply to Comments on "The Impact of Neoadjuvant Chemotherapy on the Surgical Management of Colorectal Peritoneal Metastases: A Systematic Review and Meta-analysis".
    Ann Surg Oncol. 2022;29:7935-7936.
    >> Share

  276. LIBERALE G, Moreau M, Repullo D
    Comments on "The Impact of Neoadjuvant Chemotherapy on the Surgical Management of Colorectal Peritoneal Metastases: A Systematic Review and Meta-analysis".
    Ann Surg Oncol. 2022;29:7933-7934.
    >> Share

  277. NARAYAN RR, Datta J, D'Angelica MI
    ASO Visual Abstract: Genomic Predictors of Recurrence Patterns After Complete Resection of Colorectal Liver Metastases and Adjuvant Hepatic Artery Infusion Chemotherapy.
    Ann Surg Oncol. 2022;29:7591.
    >> Share

  278. SONAL S, Deshpande V, Ting DT, Cusack JC, et al
    ASO Visual Abstract: Molecular Basis of Extramural Vascular Invasion (EMVI) in Colorectal Carcinoma : Tumor Microenvironment in EMVI-Positive Colorectal Carcinoma.
    Ann Surg Oncol. 2022;29:7384-7385.
    >> Share

  279. SONAL S, Berger DL
    ASO Author Reflections: Colorectal Cancers with Extramural Vascular Invasion Are Associated with a Low Immune Microenvironment.
    Ann Surg Oncol. 2022;29:7383.
    >> Share

  280. SONAL S, Deshpande V, Ting DT, Cusack JC, et al
    Molecular Basis of Extramural Vascular Invasion (EMVI) in Colorectal Carcinoma.
    Ann Surg Oncol. 2022;29:7372-7382.
    >> Share

  281. NARAYAN RR, Datta J, Goldman DA, Aveson VG, et al
    Genomic Predictors of Recurrence Patterns After Complete Resection of Colorectal Liver Metastases and Adjuvant Hepatic Artery Infusion Chemotherapy.
    Ann Surg Oncol. 2022;29:7579-7588.
    >> Share

  282. DELHORME JB, Sauvinet G, Severac F, Diab S, et al
    Peritoneal Metastases of Colorectal Origin Treated with Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy: The Efficiency of Mitomycin C.
    Ann Surg Oncol. 2022;29:7568-7576.
    >> Share

  283. DELHORME JB, Sauvinet G, Severac F, Diab S, et al
    ASO Visual Abstract: Peritoneal Metastases of Colorectal Origin Treated with Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy-The Efficiency of Mitomycin C.
    Ann Surg Oncol. 2022;29:7577-7578.
    >> Share

  284. NESGAARD JM, Stimec BV, Ignjatovic D
    Comments on Superior Mesenteric Artery First Approach for Right Colectomy.
    Ann Surg Oncol. 2022;29:7923-7924.
    >> Share

  285. JUDGE SJ, Cho M, Gholami S
    Genomic Predictors of Recurrence Patterns After Complete Resection of Colorectal Liver Metastases and Adjuvant Hepatic Artery Infusion Chemotherapy by Narayan et al.
    Ann Surg Oncol. 2022;29:7246-7247.
    >> Share

  286. LUO W, Lu T, Xiao Y
    Response to Letter to the Editor: "Comments to Superior Mesenteric Artery First Approach for Right Colectomy" by Jens Marius Nesgaard et al.
    Ann Surg Oncol. 2022;29:7925-7926.
    >> Share

  287. NARAYAN RR, Datta J, D'Angelica MI
    ASO Author Reflections: Ras-p53 Cooperativity Predicts Recurrence Patterns After Resection of Colorectal Liver Metastases with Adjuvant Local and Systemic Chemotherapy.
    Ann Surg Oncol. 2022;29:7589-7590.
    >> Share

  288. HEIL TC, Verdaasdonk EGG, Maas HAAM, van Munster BC, et al
    ASO Visual Abstract: Improved Postoperative Outcomes After Prehabilitation for Colorectal Cancer Surgery in Older Patients: An Emulated Target Trial.
    Ann Surg Oncol. 2022 Nov 1. pii: 10.1245/s10434-022-12720.
    >> Share

  289. DAWOOD ZS, Alaimo L, Lima HA, Moazzam Z, et al
    ASO Visual Abstract: Circulating Tumor DNA, Imaging, and Carcinoembryonic Antigen: Comparison of Surveillance Strategies in Patients Who Underwent Resection pf Colorectal Cancer: A Systematic Review and Meta-Analysis.
    Ann Surg Oncol. 2022 Nov 1. pii: 10.1245/s10434-022-12728.
    >> Share

    October 2022
  290. LAMBDIN J, Ryan CE, Alejandro RH, Baker T, et al
    Neoadjuvant Chemotherapy Plus Living Donor Transplantation (LDLT) for Non-Resectable Liver Metastases from Colorectal Cancer (CRC).
    Ann Surg Oncol. 2022 Oct 31. pii: 10.1245/s10434-022-12649.
    >> Share

  291. DAWOOD ZS, Moazzam Z, Pawlik TM
    ASO Author Reflections: Assessing the Diagnostic Accuracy of Circulating Tumor DNA, Imaging, and Carcinoembryonic Antigen to Detect Recurrent Colon Cancer.
    Ann Surg Oncol. 2022 Oct 30. pii: 10.1245/s10434-022-12678.
    >> Share

  292. KEMENY MM, Zhao F, Forastiere AA, Catalano P, et al
    Phase III Prospectively Randomized Trial of Perioperative 5-FU After Curative Resection for Colon Cancer: An Intergroup Trial of the ECOG-ACRIN Cancer Research Group (E1292).
    Ann Surg Oncol. 2022 Oct 28. pii: 10.1245/s10434-022-12705.
    >> Share

  293. SWARTJES H, van Lankveld DWP, van Erning FN, Verheul HMW, et al
    Locoregionally Recurrent Colon Cancer: How Far Have We Come? A Population-Based, Retrospective Cohort Study.
    Ann Surg Oncol. 2022 Oct 19. pii: 10.1245/s10434-022-12689.
    >> Share

  294. HEIL TC, Verdaasdonk EGG, Maas HAAM, van Munster BC, et al
    ASO Author Reflections: Real-World Effectiveness of Prehabilitation Before Colorectal Cancer Surgery: The Value of an Emulated Target Trial Design.
    Ann Surg Oncol. 2022 Oct 17. pii: 10.1245/s10434-022-12672.
    >> Share

  295. ITO K, Osakabe M, Sugimoto R, Yamada S, et al
    Differential Expression in the Tumor Microenvironment of mRNAs Closely Associated with Colorectal Cancer Metastasis.
    Ann Surg Oncol. 2022 Oct 12. pii: 10.1245/s10434-022-12574.
    >> Share

  296. AQUINA CT, Brown ZJ, Beane JD, Ejaz A, et al
    ASO Visual Abstract: Disparities in Care Access to Liver-Directed Therapy Among Medicare Beneficiaries with Colorectal Cancer Liver Metastasis.
    Ann Surg Oncol. 2022 Oct 11. pii: 10.1245/s10434-022-12652.
    >> Share

  297. DAWOOD ZS, Alaimo L, Lima HA, Moazzam Z, et al
    Circulating Tumor DNA, Imaging, and Carcinoembryonic Antigen: Comparison of Surveillance Strategies Among Patients Who Underwent Resection of Colorectal Cancer-A Systematic Review and Meta-analysis.
    Ann Surg Oncol. 2022 Oct 11. pii: 10.1245/s10434-022-12641.
    >> Share

  298. HEIL TC, Verdaasdonk EGG, Maas HAAM, van Munster BC, et al
    Improved Postoperative Outcomes after Prehabilitation for Colorectal Cancer Surgery in Older Patients: An Emulated Target Trial.
    Ann Surg Oncol. 2022 Oct 5. pii: 10.1245/s10434-022-12623.
    >> Share

  299. ITO K, Osakabe M, Sugimoto R, Yamada S, et al
    ASO Visual Abstract: Differential Expression in the Tumor Microenvironment of mRNAs Closely Associated with Colorectal Cancer Metastasis.
    Ann Surg Oncol. 2022 Oct 5. pii: 10.1245/s10434-022-12629.
    >> Share

  300. DI MARTINO M, Primavesi F, Syn N, Dorcaratto D, et al
    Long-Term Outcomes of Perioperative Versus Neoadjuvant Chemotherapy for Resectable Colorectal Liver Metastases: An International Multicentre Propensity-Score Matched Analysis with Stratification by Contemporary Risk-Scoring.
    Ann Surg Oncol. 2022;29:6829-6842.
    >> Share

  301. DI MARTINO M, Primavesi F
    ASO Author Reflections: Peri-operative Chemotherapy for Resectable Colorectal Liver Metastases.
    Ann Surg Oncol. 2022;29:6843-6844.
    >> Share

  302. DI MARTINO M, Primavesi F, Syn N, Dorcaratto D, et al
    ASO Visual Abstract: Long-Term Outcomes of Perioperative versus Neoadjuvant Chemotherapy for Resectable Colorectal Liver Metastases-An International Multicenter Propensity-Score Matched Analysis with Stratification by Contemporary Risk Scoring.
    Ann Surg Oncol. 2022;29:6845-6846.
    >> Share

  303. HORI Y, Seo S, Yoh T, Ueno K, et al
    Impact of Preoperative CEA Uptrend on Survival Outcomes in Patients with Colorectal Liver Metastasis After Hepatectomy.
    Ann Surg Oncol. 2022;29:6745-6754.
    >> Share

  304. HORI Y, Seo S
    ASO Author Reflections: CEA Uptrend is a Useful Biomarker to Predict Post-Hepatectomy Survival Outcomes in Patients with Colorectal Liver Metastasis.
    Ann Surg Oncol. 2022;29:6755-6756.
    >> Share

  305. DIETZ MV, van Kooten JP, Said I, Brandt-Kerkhof ARM, et al
    Survival Outcomes After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy in Patients with Synchronous Versus Metachronous Onset of Peritoneal Metastases of Colorectal Carcinoma.
    Ann Surg Oncol. 2022;29:6566-6576.
    >> Share

  306. DIETZ MV, Madsen EVE
    ASO Author Reflections: The Timing of Onset of Peritoneal Metastases from Colorectal Carcinoma Is Not an Independent Predictor of Survival Outcomes After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy.
    Ann Surg Oncol. 2022;29:6577-6578.
    >> Share

  307. FLOOD MP, Ramsay R, Michael M, Heriot AG, et al
    ASO Author Reflections: Neoadjuvant Systemic Chemotherapy in Isolated Resectable Colorectal Peritoneal Metastases: Ready for Standard of Care?
    Ann Surg Oncol. 2022;29:6632-6633.
    >> Share

  308. FLOOD MP, Kong JCH, Wilson K, Mohan H, et al
    The Impact of Neoadjuvant Chemotherapy on the Surgical Management of Colorectal Peritoneal Metastases: A Systematic Review and Meta-Analysis.
    Ann Surg Oncol. 2022;29:6619-6631.
    >> Share

  309. WHITE MG, Badgwell B
    Oncologic Components of HIPEC: Key Question : In patients with gastric or colorectal adenocarcinoma metastatic to the peritoneum, does cytoreductive surgery (CRS) plus hyperthermic intraperitoneal perfusion with chemotherapy (HIPEC) prolong survival o
    Ann Surg Oncol. 2022;29:6561-6564.
    >> Share

    September 2022
  310. YOSHIKAWA Y, Fukunaga M, Takahashi J, Shimizu D, et al
    Identification of the Minimum Combination of Serum microRNAs to Predict the Recurrence of Colorectal Cancer Cases.
    Ann Surg Oncol. 2022 Sep 29. pii: 10.1245/s10434-022-12355.
    >> Share

  311. AQUINA CT, Brown ZJ, Beane JD, Ejaz A, et al
    Disparities in Care Access to Liver-Directed Therapy Among Medicare Beneficiaries with Colorectal Cancer Liver Metastasis.
    Ann Surg Oncol. 2022 Sep 23. pii: 10.1245/s10434-022-12513.
    >> Share

  312. PEDRAZZANI C, Turri G, Marrelli D, Kim HJ, et al
    ASO Visual Abstract: Prediction of Metachronous Peritoneal Metastases After Radical Surgery for Colon Cancer: A Scoring System Obtained from an International Multicenter Cohort.
    Ann Surg Oncol. 2022 Sep 4. pii: 10.1245/s10434-022-12473.
    >> Share

  313. SOULEN MC, White SB
    Another Signal from DEBIRI.
    Ann Surg Oncol. 2022;29:5357-5358.
    >> Share

  314. VIGANO L, Branciforte B, Laurenti V, Costa G, et al
    The Histopathological Growth Pattern of Colorectal Liver Metastases Impacts Local Recurrence Risk and the Adequate Width of the Surgical Margin.
    Ann Surg Oncol. 2022;29:5515-5524.
    >> Share

  315. DIETZ MV, van Kooten JP, van Vugt JLA, Brandt-Kerkhof ARM, et al
    The Impact of Low Skeletal Muscle Mass on Short- and Long-Term Outcomes After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
    Ann Surg Oncol. 2022;29:5830-5841.
    >> Share

  316. LEIGH N, Williams GA, Strasberg SM, Fields RC, et al
    Increased Morbidity and Mortality After Hepatectomy for Colorectal Liver Metastases in Frail Patients is Largely Driven by Worse Outcomes After Minor Hepatectomy: It's Not "Just a Wedge".
    Ann Surg Oncol. 2022;29:5476-5485.
    >> Share

  317. VIGANO L, Branciforte B, Laurenti V, Torzilli G, et al
    ASO Author Reflections: The Histopathological Growth Pattern of Colorectal Liver Metastases: A New Biomarker to Drive Surgical Strategy.
    Ann Surg Oncol. 2022;29:5525-5526.
    >> Share

  318. PARO A, Hyer JM, Shaikh CF, Pawlik TM, et al
    Financial Impact of Out-of-Pocket Costs Among Patients Undergoing Resection for Colorectal Carcinoma.
    Ann Surg Oncol. 2022;29:5387-5397.
    >> Share

  319. PARO A, Pawlik TM
    ASO Author Reflections: The Financial Impact of Out-of-Pocket Costs Among Patients Undergoing Resection for Colorectal Carcinoma.
    Ann Surg Oncol. 2022;29:5398-5399.
    >> Share

    August 2022
  320. PARK EJ, Ahn J, Abuzar SM, Park KS, et al
    Pharmacologic Effects of Oxaliplatin Instability in Chloride-Containing Carrier Fluids on the Hyperthermic Intraperitoneal Chemotherapy to Treat Colorectal Cancer In Vitro and In Vivo.
    Ann Surg Oncol. 2022 Aug 30. pii: 10.1245/s10434-022-12358.
    >> Share

  321. PARK EJ, Ahn J, Abuzar SM, Park KS, et al
    ASO Visual Abstract: Pharmacologic Effects of Oxaliplatin Instability in Chloride-Containing Carrier Fluids on the Hyperthermic Intraperitoneal Chemotherapy to Treat Colorectal Cancer In Vitro and In Vivo.
    Ann Surg Oncol. 2022 Aug 27. pii: 10.1245/s10434-022-12393.
    >> Share

  322. YOSHINO K, Osumi H, Ito H, Kamiimabeppu D, et al
    ASO Visual Abstract: Clinical Usefulness of Postoperative Serum Carcinoembryonic Antigen in Patients with Colorectal Cancer with Liver Metastases.
    Ann Surg Oncol. 2022 Aug 21. pii: 10.1245/s10434-022-12336.
    >> Share

  323. YOSHINO K, Osumi H, Ito H, Kamiimabeppu D, et al
    Clinical Usefulness of Postoperative Serum Carcinoembryonic Antigen in Patients with Colorectal Cancer with Liver Metastases.
    Ann Surg Oncol. 2022 Aug 16. pii: 10.1245/s10434-022-12301.
    >> Share

  324. ZOU M, Gui MB, Gao H, Gao F, et al
    Comment on "Association of Albumin-Bilirubin Grade and Myosteatosis with its Prognostic Significance for Patients with Colorectal Cancer".
    Ann Surg Oncol. 2022 Aug 13. pii: 10.1245/s10434-022-12376.
    >> Share

  325. KANG J
    Reply to Letter by Min Zou et al.: Comment on "Association of Albumin-Bilirubin Grade and Myosteatosis with its Prognostic Significance for Patients with Colorectal Cancer".
    Ann Surg Oncol. 2022 Aug 6. pii: 10.1245/s10434-022-12377.
    >> Share

  326. YOSHINO K, Osumi H, Ito H, Yamaguchi K, et al
    ASO Author Reflections: The Role of CEA Optimizing Perioperative Treatments for Colorectal Cancer with Liver Metastases.
    Ann Surg Oncol. 2022 Aug 6. pii: 10.1245/s10434-022-12372.
    >> Share

  327. KLEMEN ND, Court CM, Fernandes MC, Walch HS, et al
    Local Therapy for Oligoprogression or Consolidation in High Mutational Burden Stage 4 Colorectal Cancer Treated With PD-1 or PD-L1 Blockade.
    Ann Surg Oncol. 2022 Aug 5. pii: 10.1245/s10434-022-12095.
    >> Share

  328. HAGIHARA K, Haraguchi N, Nishimura J, Yasueda A, et al
    PLXND1/SEMA3E Promotes Epithelial-Mesenchymal Transition Partly via the PI3K/AKT-Signaling Pathway and Induces Heterogenity in Colorectal Cancer.
    Ann Surg Oncol. 2022 Aug 2. pii: 10.1245/s10434-022-11945.
    >> Share

  329. LUO W, Lu T, Xiao Y
    ASO Author Reflections: A New "Superior Mesenteric Artery-First" Approach for Complete Mesocolic Excision with Central Vascular Ligation in Laparoscopic Right Hemicolectomy.
    Ann Surg Oncol. 2022;29:5074-5075.
    >> Share

  330. COSTANTINI B, Vargiu V, Santullo F, Rosati A, et al
    Risk Factors for Anastomotic Leakage in Advanced Ovarian Cancer Surgery: A Large Single-Center Experience.
    Ann Surg Oncol. 2022;29:4791-4802.
    >> Share

  331. SAID I, Ubink I, Ewalds RSG, Arkesteijn JGT, et al
    In Patients Undergoing CRS/HIPEC for Colorectal Adenocarcinoma with Peritoneal Metastases, Presence of Ascites on Computed Tomography Imaging is not a Prognostic Marker for Survival.
    Ann Surg Oncol. 2022;29:5256-5262.
    >> Share

  332. MASON MC, Krasnodebski M, Hester CA, Kothari AN, et al
    Outcomes of Mixed Pathologic Response in Patients with Multiple Colorectal Liver Metastases Treated with Neoadjuvant Chemotherapy and Liver Resection.
    Ann Surg Oncol. 2022;29:5156-5164.
    >> Share

  333. TAIBI A, Hubner M, Eveno C, Dumont F, et al
    ASO Author Reflections: Is There Still a Role for Intraperitoneal Oxaliplatin for Colorectal Peritoneal Metastases?
    Ann Surg Oncol. 2022;29:5252-5253.
    >> Share

  334. AIBUEDEFE B, Hamilton KS, Yong V, Kling SM, et al
    It's Not About the Money: Continued Treatment and Survival Outcome Disparities in Minority Rectal Cancer Patients After Controlling for Socioeconomic Factors.
    Ann Surg Oncol. 2022;29:5056-5062.
    >> Share

  335. TAIBI A, Sgarbura O, Hubner M, Bardet SM, et al
    Feasibility and Safety of Oxaliplatin-Based Pressurized Intraperitoneal Aerosol Chemotherapy With or Without Intraoperative Intravenous 5-Fluorouracil and Leucovorin for Colorectal Peritoneal Metastases: A Multicenter Comparative Cohort Study.
    Ann Surg Oncol. 2022;29:5243-5251.
    >> Share

  336. HAMILTON KS, Aibuedefe B, Yong V, Kling SM, et al
    ASO Author Reflections: Inequities in Rectal Cancer Treatment and Survival.
    Ann Surg Oncol. 2022;29:5063-5064.
    >> Share

  337. CARBONI F, Valle M
    Letter to Editor of Annals of Surgical Oncology Concerning "Early Diagnosis of Anastomotic Leakage after Gastric Cancer Surgery via Analysis of Inflammatory Factors in Abdominal Drainage".
    Ann Surg Oncol. 2022;29:5107-5108.
    >> Share

  338. HAGIHARA K, Haraguchi N, Nishimura J, Yasueda A, et al
    ASO Visual Abstract: PLXND1/SEMA3E Promotes EMT Partly via the PI3K/AKT Signaling Pathway and Induces Heterogeneity in Colorectal Cancer.
    Ann Surg Oncol. 2022 Aug 1. pii: 10.1245/s10434-022-12111.
    >> Share

  339. ANGKA L, Martel AB, Ng J, Pecarskie A, et al
    ASO Visual Abstract: A Translational Randomized Trial of Perioperative Arginine Immunonutrition on Natural Killer Cell Function in Colorectal Cancer Surgery Patients.
    Ann Surg Oncol. 2022 Aug 1. pii: 10.1245/s10434-022-12281.
    >> Share

    July 2022
  340. SINGH J, Kannan A, Pant A, Paruthy E, et al
    Effect of Socioeconomic Inequalities on the Surgical Treatment and Outcomes of Patients with Colon Cancer.
    Ann Surg Oncol. 2022 Jul 29. pii: 10.1245/s10434-022-12316.
    >> Share

  341. ANGKA L, Martel AB, Ng J, Pecarskie A, et al
    A Translational Randomized Trial of Perioperative Arginine Immunonutrition on Natural Killer Cell Function in Colorectal Cancer Surgery Patients.
    Ann Surg Oncol. 2022 Jul 25. pii: 10.1245/s10434-022-12202.
    >> Share

  342. SAMPURNO S, Chittleborough T, Dean M, Flood M, et al
    ASO Visual Abstract: Effect of Surgical Humidification on Inflammation and Peritoneal Trauma in Colorectal Cancer Surgery-A Randomised Controlled Trial.
    Ann Surg Oncol. 2022 Jul 25. pii: 10.1245/s10434-022-12241.
    >> Share

  343. HAWKINS AT
    I've Got Bad News and Bad News: The Cost of Colorectal Cancer Care.
    Ann Surg Oncol. 2022 Jul 13. pii: 10.1245/s10434-022-12172.
    >> Share

  344. PEDRAZZANI C, Turri G, Choi GS
    ASO Author Reflections: Toward the Prediction of Peritoneal Recurrence After Curative Resection for Colon Cancer.
    Ann Surg Oncol. 2022 Jul 12. pii: 10.1245/s10434-022-12180.
    >> Share

  345. SAMPURNO S, Chittleborough T, Dean M, Flood M, et al
    Effect of Surgical Humidification on Inflammation and Peritoneal Trauma in Colorectal Cancer Surgery: A Randomized Controlled Trial.
    Ann Surg Oncol. 2022 Jul 6. pii: 10.1245/s10434-022-12057.
    >> Share

  346. PEDRAZZANI C, Turri G, Marrelli D, Kim HJ, et al
    Prediction of Metachronous Peritoneal Metastases After Radical Surgery for Colon Cancer: A Scoring System Obtained from an International Multicenter Cohort.
    Ann Surg Oncol. 2022 Jul 5. pii: 10.1245/s10434-022-12097.
    >> Share

  347. MATSUGUMA H, Mun M, Sano A, Yoshino I, et al
    ASO Visual Abstract: Time to Incurable Recurrence for Patients Who Receive Pulmonary Metastasectomy for Colorectal Cancer.
    Ann Surg Oncol. 2022 Jul 4. pii: 10.1245/s10434-022-12073.
    >> Share

    June 2022
  348. TANG W, Liu Y, Ji M, Liu T, et al
    Correction to: Association of RAS/BRAF Status and Prognosis of Metastatic Colorectal Cancer: Analysis of 1002 Consecutive Cases.
    Ann Surg Oncol. 2022 Jun 24. pii: 10.1245/s10434-022-12051.
    >> Share

  349. MATSUGUMA H, Mun M, Sano A, Yoshino I, et al
    Time to Incurable Recurrence for Patients Treated With Pulmonary Metastasectomy for Colorectal Cancer.
    Ann Surg Oncol. 2022 Jun 18. pii: 10.1245/s10434-022-11904.
    >> Share

  350. THEISS LM, Lucy AT, Bergstresser SL, Chu DI, et al
    Disparities in Surgical Timing and Guideline-Adherent Staging Work-Up for Colon Cancer.
    Ann Surg Oncol. 2022 Jun 6. pii: 10.1245/s10434-022-11938.
    >> Share

  351. TONELLO M, Baratti D, Sammartino P, Di Giorgio A, et al
    ASO Visual Abstract: Microsatellite and RAS/RAF Mutational Status as Prognostic Factors in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
    Ann Surg Oncol. 2022;29:3420-3421.
    >> Share

  352. ZHU HB, Xu D, Zhang XY, Li XT, et al
    ASO Visual Abstract: Prediction of Therapeutic Effect of Treatment on Patients with Colorectal Liver Metastases Using Functional Magnetic Resonance Imaging and RECIST Criteria: A Pilot Study Comparing Bevacizumab-Containing Chemotherapy and Standard C
    Ann Surg Oncol. 2022;29:3950.
    >> Share

  353. OMICHI K, Inoue Y, Mise Y, Oba A, et al
    ASO Visual Abstract: Hepatectomy with Perioperative Chemotherapy for Multiple Colorectal Liver Metastases is the Available Option for Prolonged Survival.
    Ann Surg Oncol. 2022;29:3577.
    >> Share

  354. KHIN NY, De Silva M, Clarke S, Pavlakis N, et al
    Liver Isolation Oxaliplatin (LIOX): Long Term Survival from a New Locoregional Technique for Chemorefractory Patients with Colorectal Liver Metastases.
    Ann Surg Oncol. 2022;29:3387-3389.
    >> Share

  355. OMICHI K, Inoue Y, Mise Y, Oba A, et al
    Hepatectomy with Perioperative Chemotherapy for Multiple Colorectal Liver Metastases is the Available Option for Prolonged Survival.
    Ann Surg Oncol. 2022;29:3567-3576.
    >> Share

  356. ZHU HB, Xu D, Zhang XY, Li XT, et al
    Prediction of Therapeutic Effect to Treatment in Patients with Colorectal Liver Metastases Using Functional Magnetic Resonance Imaging and RECIST Criteria: A Pilot Study in Comparison between Bevacizumab-Containing Chemotherapy and Standard Chemothera
    Ann Surg Oncol. 2022;29:3938-3949.
    >> Share

  357. TONELLO M, Baratti D, Sammartino P, Di Giorgio A, et al
    Microsatellite and RAS/RAF Mutational Status as Prognostic Factors in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC).
    Ann Surg Oncol. 2022;29:3405-3417.
    >> Share

  358. TONELLO M, Sommariva A
    ASO Author Reflections: Microsatellite and RAS/RAF Mutational Status as Prognostic Factors in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC).
    Ann Surg Oncol. 2022;29:3418-3419.
    >> Share

    May 2022
  359. DIAZ VICO T, Garcia Florez LJ
    Letter to the Editor Reply: 'Mesocolon Excision in Right Colon Cancer: Is it a Real Oncological Procedure or a Mere Surgical Act?'
    Ann Surg Oncol. 2022 May 9. pii: 10.1245/s10434-022-11879.
    >> Share

  360. GRAZIOSI L, Marino E
    Mesocolon Excision in Right Colon Cancer: Is it a Real Oncological Procedure or a Mere Surgical Act?
    Ann Surg Oncol. 2022 May 5. pii: 10.1245/s10434-022-11872.
    >> Share

  361. FOSTER JM, Zhang C
    ASO Author Reflections: Palliative Management of Peritoneal Metastasis Exploring the Risks and Benefits of CRS/HIPEC, a Distinctly Different Context Than Early CRS/HIPEC Intervention With 'Curative Intent'.
    Ann Surg Oncol. 2022;29:3347-3348.
    >> Share

  362. ZHANG C, Patel A, Hegeholz D, Brown K, et al
    Cytoreductive Surgery with HIPEC is a Safe and Effective Palliative Option in Chemorefractory Symptomatic Peritoneal Metastasis.
    Ann Surg Oncol. 2022;29:3337-3346.
    >> Share

  363. TEO QT, Koh FH, Ladlad J, Foo FJ, et al
    Laparoscopic Anterior Resection with Anastomosis of Mid-Transverse to Distal Rectum with Deloyers Procedure Under Indocyanine Green fluorescence Guidance: A Video Case Report.
    Ann Surg Oncol. 2022;29:3071.
    >> Share

  364. MATSUDA T, Sawada R, Hasegawa H, Yamashita K, et al
    Standardized Procedure of Transperineal Minimally Invasive Abdominoperineal Resection for Low Rectal Cancer.
    Ann Surg Oncol. 2022;29:3065.
    >> Share

  365. KAMARAJAH SK, Griffiths EA, Phillips AW, Ruurda J, et al
    ASO Visual Abstract: Robotic Techniques in Esophagogastric Cancer Surgery: An Assessment of Short- and Long-Term Clinical Outcomes.
    Ann Surg Oncol. 2022;29:2828-2829.
    >> Share

  366. SUN Y, Yang H, Zhang Z, Zhou Y, et al
    ASO Visual Abstract: Laparoscopic Pelvic Exenteration with Bladder Sparing for Men with Locally Advanced Rectal Cancer.
    Ann Surg Oncol. 2022;29:3069-3070.
    >> Share

  367. MATSUDA T
    ASO Author Reflections: What is the Most Reasonable Approach to Abdominoperineal Resection for Low Rectal Cancer?
    Ann Surg Oncol. 2022;29:3066.
    >> Share

  368. SUN Y, Yang H, Zhang Z, Zhou Y, et al
    Laparoscopic Pelvic Exenteration with Bladder Sparing for Men with Locally Advanced Rectal Cancer (with Video).
    Ann Surg Oncol. 2022;29:3067-3068.
    >> Share

  369. YAMADA T, Matsuda A, Takahashi G, Yoshida H, et al
    Oncological Risk of Colonic Stents Used as Bridge to Surgery for Left-Side Malignant Colonic Obstructions.
    Ann Surg Oncol. 2022;29:2759-2760.
    >> Share

    April 2022
  370. LUO W, Cai Z, Li F, Lu T, et al
    Laparoscopic Complete Mesocolic Excision with Central Vascular Ligation (CME + CVL) for Right-Sided Colon Cancer: A New "Superior Mesenteric Artery First" Approach.
    Ann Surg Oncol. 2022 Apr 19. pii: 10.1245/s10434-022-11773.
    >> Share

  371. KOH HH, Cho ES, Lee JH, Shin SJ, et al
    ASO Visual Abstract: Association Between Albumin-Bilirubin Grade and Myosteatosis and Its Prognostic Significance for Patients with Colorectal Cancer.
    Ann Surg Oncol. 2022 Apr 5. pii: 10.1245/s10434-022-11552.
    >> Share

  372. ROUANET P, Selvy M, Jarlier M, Bugnon C, et al
    Tailored Management with Highly-Selective Diversion for Low Colorectal Anastomosis: Biochemical Postoperative Follow-Up and Long-Term Results from a Single-Institution Cohort.
    Ann Surg Oncol. 2022;29:2514-2524.
    >> Share

  373. TAKEDA Y, Mise Y, Takahashi Y, Ito H, et al
    Limited Prognostic Value of KRAS in Patients Undergoing Hepatectomy for Colorectal Liver Metastases.
    Ann Surg Oncol. 2022;29:2383-2391.
    >> Share

  374. NIE RC, Chen GM, Yuan SQ, Kim JW, et al
    Adjuvant Chemotherapy for Gastric Cancer Patients with Mismatch Repair Deficiency or Microsatellite Instability: Systematic Review and Meta-Analysis.
    Ann Surg Oncol. 2022;29:2324-2331.
    >> Share

  375. ERSTAD DJ, Dasari A, Taggart MW, Kaur H, et al
    Prognosis for Poorly Differentiated, High-Grade Rectal Neuroendocrine Carcinomas.
    Ann Surg Oncol. 2022;29:2539-2548.
    >> Share

  376. EADS JR
    Is it Time Yet for Adjuvant Immunotherapy for Patients with DNA Mismatch Repair Deficient Gastric Cancer?
    Ann Surg Oncol. 2022;29:2141-2143.
    >> Share

  377. ROUANET P, Selvy M, Jarlier M, Bugnon C, et al
    ASO Visual Abstract: Tailored Management with Highly Selective Diversion for Low Colorectal Anastomosis-Biochemical Postoperative Follow-Up and Long-Term Results from a Single-Institution Cohort.
    Ann Surg Oncol. 2022;29:2525-2526.
    >> Share

  378. MANGIERI CW, Moaven O, Valenzuela CD, Erali RA, et al
    ASO Visual Abstract: Utility of Neoadjuvant Chemotherapy for Peritoneal Carcinomatosis Secondary to High-Grade Appendiceal Neoplasms for Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy.
    Ann Surg Oncol. 2022;29:2651.
    >> Share

  379. TAKEDA Y, Mise Y, Takahashi Y, Ito H, et al
    ASO Visual Abstract: Limited Prognostic Value of KRAS for Patients Undergoing Hepatectomy for Colorectal Liver Metastases.
    Ann Surg Oncol. 2022;29:2392.
    >> Share

  380. NIE R, Kim JW, Chen G, Li YF, et al
    ASO Author Reflections: Adjuvant Chemotherapy Should not be Omitted for Gastric Cancer Patients with Mismatch Repair Deficiency or Microsatellite Instability.
    Ann Surg Oncol. 2022;29:2332-2333.
    >> Share

    March 2022
  381. TANG W, Liu Y, Ji M, Liu T, et al
    Association of RAS/BRAF Status and Prognosis of Metastatic Colorectal Cancer: Analysis of 1002 Consecutive Cases.
    Ann Surg Oncol. 2022 Mar 17. pii: 10.1245/s10434-021-11302.
    >> Share

  382. LEE SJ, Kang J, Baik SH, Park EJ, et al
    ASO Visual Abstract: Impact of Mitomycin-C-Induced Neutropenia After Hyperthermic Intraperitoneal Chemotherapy with Cytoreductive Surgery in Colorectal Cancer Patients with Peritoneal Carcinomatosis.
    Ann Surg Oncol. 2022 Mar 7. pii: 10.1245/s10434-022-11493.
    >> Share

  383. SEBAI A, Tzedakis S, Livin M, Sulpice L, et al
    Prosthetic Reconstruction of the Cavo-Hepatic Venous Confluence for a Colorectal Cancer Liver Recurrence.
    Ann Surg Oncol. 2022 Mar 3. pii: 10.1245/s10434-022-11378.
    >> Share

  384. MARCHEGIANI F, Palatucci V, Capelli G, Guerrieri M, et al
    Rectal Sparing Approach After Neoadjuvant Therapy in Patients with Rectal Cancer: The Preliminary Results of the ReSARCh Trial.
    Ann Surg Oncol. 2022;29:1880-1889.
    >> Share

  385. LAW CK, Stevenson ARL, Solomon M, Hague W, et al
    Healthcare Costs of Laparoscopic versus Open Surgery for Rectal Cancer Patients in the First 12 Months: A Secondary Endpoint Analysis of the Australasian Laparoscopic Cancer of the Rectum Trial (ALaCaRT).
    Ann Surg Oncol. 2022;29:1923-1934.
    >> Share

  386. POLDERDIJK MCE, Brouwer M, Haverkamp L, Ziesemer KA, et al
    Outcomes of Combined Peritoneal and Local Treatment for Patients with Peritoneal and Limited Liver Metastases of Colorectal Origin: A Systematic Review and Meta-Analysis.
    Ann Surg Oncol. 2022;29:1952-1962.
    >> Share

  387. NIZRI E, Berger Y, Green E, Kyzer M, et al
    Lymph Node Metastases from Visceral Peritoneal Colorectal Metastases are Associated with Systemic Recurrence.
    Ann Surg Oncol. 2022;29:2069-2075.
    >> Share

  388. BURGHGRAEF TA, Hol JC, Rutgers ML, Crolla RMPH, et al
    Laparoscopic Versus Robot-Assisted Versus Transanal Low Anterior Resection: 3-Year Oncologic Results for a Population-Based Cohort in Experienced Centers.
    Ann Surg Oncol. 2022;29:1910-1920.
    >> Share

  389. CUI CL, Luo WY, Cosman BC, Eisenstein S, et al
    Cost Effectiveness of Watch and Wait Versus Resection in Rectal Cancer Patients with Complete Clinical Response to Neoadjuvant Chemoradiation.
    Ann Surg Oncol. 2022;29:1894-1907.
    >> Share

  390. MARCHEGIANI F, Palatucci V, Capelli G, Guerrieri M, et al
    ASO Visual Abstract: Rectal Sparing Approach After Neoadjuvant Therapy in Patients with Rectal Cancer: The Preliminary Results of the ReSARCh Trial.
    Ann Surg Oncol. 2022;29:1892-1893.
    >> Share

  391. PEREZ RO
    Cost-Effectiveness of Watch and Wait: What is in the Box of this Organ-Preservation Strategy?
    Ann Surg Oncol. 2022;29:1516-1517.
    >> Share

  392. MARCHEGIANI F, Spolverato G, Pucciarelli S
    ASO Author Reflections: Rectal Preservation After Major or Complete Clinical Response to Neoadjuvant Therapy-The Safety of Integrated Approaches.
    Ann Surg Oncol. 2022;29:1890-1891.
    >> Share

  393. GOFFREDO P, Smith JJ
    The Paradox of Early Stage Rectal Cancer: More ReSeARCh in the Right Direction.
    Ann Surg Oncol. 2022;29:1513-1515.
    >> Share

  394. WEISER MR
    Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: PRODIGE 23 Trial.
    Ann Surg Oncol. 2022;29:1493-1495.
    >> Share

  395. CUI CL, Luo WY, Cosman BC, Eisenstein S, et al
    ASO Author Reflections: Bang for Your Buck-Implications of the Cost-Effectiveness of Watchful Waiting Versus Radical Surgery for Locally Advanced Rectal Cancer After Successful Neoadjuvant Chemoradiation.
    Ann Surg Oncol. 2022;29:1908-1909.
    >> Share

    February 2022
  396. KOH HH, Kang J
    ASO Author Reflections: Albumin-Bilirubin Grade and Myosteatosis as Potential Cancer Cachexia-Related Indicators in Patients with Colorectal Cancer.
    Ann Surg Oncol. 2022 Feb 26. pii: 10.1245/s10434-022-11489.
    >> Share

  397. SEBAI A, Boudjema K
    ASO Author Reflections: Resection of Colorectal Cancer Liver Metastasis with Vascular Invasion.
    Ann Surg Oncol. 2022 Feb 26. pii: 10.1245/s10434-022-11459.
    >> Share

  398. KOH HH, Cho ES, Lee JH, Shin SJ, et al
    Association of Albumin-Bilirubin Grade and Myosteatosis with its Prognostic Significance for Patients with Colorectal Cancer.
    Ann Surg Oncol. 2022 Feb 24. pii: 10.1245/s10434-022-11445.
    >> Share

  399. KIM JK, Thompson H, Jimenez-Rodriguez RM, Wu F, et al
    Adoption of Organ Preservation and Surgeon Variability for Patients with Rectal Cancer Does Not Correlate with Worse Survival.
    Ann Surg Oncol. 2022;29:1172-1179.
    >> Share

  400. KROON HM, Dudi-Venkata NN, Bedrikovetski S, Liu J, et al
    Malignant Features in Pretreatment Metastatic Lateral Lymph Nodes in Locally Advanced Low Rectal Cancer Predict Distant Metastases.
    Ann Surg Oncol. 2022;29:1194-1203.
    >> Share

  401. SIMUNOVIC M, Grubac V, Hillis C, Yang I, et al
    Identification and Adjudication of Adverse Events Following Rectal Cancer Surgery: Observational Case Series in a Region of Ontario, Canada.
    Ann Surg Oncol. 2022;29:1182-1191.
    >> Share

  402. PAMEIJER CR
    HIPEC Trials and the US: A Review and Call to Action.
    Ann Surg Oncol. 2022;29:866-872.
    >> Share

  403. KIM JK, Garcia-Aguilar J
    ASO Author Reflections: Identifying Rectal Cancer Patients Suitable for Watch-and-Wait.
    Ann Surg Oncol. 2022;29:1180.
    >> Share

  404. KROON HM, Kusters M, Sammour T
    ASO Author Reflection: Lateral Pelvic Lymph Nodes in Rectal Cancer-Not All Are Created Equal.
    Ann Surg Oncol. 2022;29:1204-1205.
    >> Share

    January 2022
  405. LEECH MM, Weiss JE, Markey C, Loehrer AP, et al
    ASO Author Reflections: Intersectionality of Social Determinants of Health in Lung and Colorectal Cancer Diagnosis and Treatment.
    Ann Surg Oncol. 2022 Jan 16. pii: 10.1245/s10434-021-11224.
    >> Share

  406. KANTERS A, Liska D
    The Impact of Ulcerative Colitis on Colorectal Cancer Prognosis: The Jury is Still Out.
    Ann Surg Oncol. 2022 Jan 11. pii: 10.1245/s10434-021-11307.
    >> Share

  407. LEECH MM, Weiss JE, Markey C, Loehrer AP, et al
    Influence of Race, Insurance, Rurality, and Socioeconomic Status on Equity of Lung and Colorectal Cancer Care.
    Ann Surg Oncol. 2022 Jan 7. pii: 10.1245/s10434-021-11160.
    >> Share

  408. VERHEIJ FS, Soares KC, Beets GL, Kok NFM, et al
    ASO Visual Abstract: Timing of Primary Tumor Resection in Synchronous Metastatic Colon Cancer Patients Undergoing Hepatic Arterial Infusion Pump Placement.
    Ann Surg Oncol. 2022 Jan 7. pii: 10.1245/s10434-021-11106.
    >> Share

  409. LEECH MM, Weiss JE, Markey C, Loehrer AP, et al
    ASO Visual Abstract: Influence of Race, Insurance, Rurality, and Socioeconomic Status on Equity of Lung and Colorectal Cancer Care.
    Ann Surg Oncol. 2022 Jan 3. pii: 10.1245/s10434-021-11247.
    >> Share

  410. DUMONT F, Barreteau T, Simon G, Loaec C, et al
    Laparoscopic Extraperitoneal Approach to Bilateral Pelvic Lymph Node Dissection in Low Rectal Cancer: Technique with Video and 3D Modeling.
    Ann Surg Oncol. 2022;29:109-111.
    >> Share

  411. YAMADA S, Takiyama H, Isozaki Y, Shinoto M, et al
    Carbon Ion Radiotherapy for Locally Recurrent Rectal Cancer of Patients with Prior Pelvic Irradiation.
    Ann Surg Oncol. 2022;29:99-106.
    >> Share

  412. GARCIA-FADRIQUE A, Estevan Estevan R, Sabater Orti L
    Quality Standards for Surgery of Colorectal Peritoneal Metastasis After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
    Ann Surg Oncol. 2022;29:188-202.
    >> Share

  413. YAMADA S, Takiyama H, Isozaki Y, Shinoto M, et al
    ASO Visual Abstract: Carbon Ion Radiotherapy for Locally Recurrent Rectal Cancer in Patients with Prior Pelvic Irradiation.
    Ann Surg Oncol. 2022;29:107-108.
    >> Share

  414. NOTICEWALA SS, Das P
    Carbon Ion Radiotherapy for Locally Recurrent Rectal Cancer.
    Ann Surg Oncol. 2022;29:11-12.
    >> Share

  415. GARCIA-FADRIQUE A
    ASO Author Reflections: Cytoreductive Surgery for Colorectal Peritoneal Metastases-Is It Time to Audit Our Results?
    Ann Surg Oncol. 2022;29:203-204.
    >> Share

  416. RAOOF M, Dellinger T
    ASO Author Reflections: Defining the Role of PIPAC in the Treatment of Peritoneal Metastases.
    Ann Surg Oncol. 2022;29:186-187.
    >> Share

    December 2021
  417. KEMPER M, Izbicki JR, Reeh M
    Is There an Optimal Definition for a Positive Circumferential Resection Margin in Locally Advanced Esophageal Cancer?
    Ann Surg Oncol. 2021;28:8020-8021.
    >> Share

  418. BRAC B, Dufour C, Behal H, Vanderbeken M, et al
    Is There an Optimal Definition for a Positive Circumferential Resection Margin in Locally Advanced Esophageal Cancer?
    Ann Surg Oncol. 2021;28:8337-8346.
    >> Share

  419. BROHOLM M, Degett TH, Furbo S, Fiehn AK, et al
    Colonic Stent as Bridge to Surgery for Malignant Obstruction Induces Gene Expressional Changes Associated with a More Aggressive Tumor Phenotype.
    Ann Surg Oncol. 2021;28:8519-8531.
    >> Share

  420. GIULIANTE F, Vigano L, De Rose AM, Adam R, et al
    ASO Author Reflections: The Liver-First Approach: A New Standard for Patients with Multiple Bilobar Colorectal Metastases?
    Ann Surg Oncol. 2021;28:8209-8210.
    >> Share

  421. SHIN JK, Park YA, Huh JW, Yun SH, et al
    Tumor Budding as a Prognostic Marker in Rectal Cancer Patients on Propensity Score Analysis.
    Ann Surg Oncol. 2021;28:8813-8822.
    >> Share

  422. RIESER CJ, Jones H, Hall LB, Kang E, et al
    Definition and Prediction of Early Recurrence and Mortality Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases: Towards Predicting Oncologic Futility Preoperatively.
    Ann Surg Oncol. 2021;28:9116-9125.
    >> Share

  423. GIULIANTE F, Vigano L, De Rose AM, Mirza DF, et al
    Liver-First Approach for Synchronous Colorectal Metastases: Analysis of 7360 Patients from the LiverMetSurvey Registry.
    Ann Surg Oncol. 2021;28:8198-8208.
    >> Share

  424. BRAHMBHATT RD, Tee MC, Franko J
    Robotic Isolated Caudate Lobectomy for Solitary Colorectal Liver Metastasis.
    Ann Surg Oncol. 2021;28:8236-8237.
    >> Share

  425. BAKKERS C, Lurvink RJ, Rijken A, Nienhuijs SW, et al
    Treatment Strategies and Prognosis of Patients With Synchronous or Metachronous Colorectal Peritoneal Metastases: A Population-Based Study.
    Ann Surg Oncol. 2021;28:9073-9083.
    >> Share

  426. JIANG W, Li M, Tan J, Feng M, et al
    ASO Visual Abstract: A Nomogram Based on a Collagen Feature Support Vector Machine for Predicting the Treatment Response to Neoadjuvant Chemoradiotherapy in Rectal Cancer Patients.
    Ann Surg Oncol. 2021;28.
    >> Share

  427. BAKKERS C, Lurvink RJ, Rijken A, Nienhuijs SW, et al
    ASO Visual Abstract: Treatment Strategies and Prognosis in Patients with Synchronous or Metachronous Colorectal Peritoneal Metastases: A Population-Based Study.
    Ann Surg Oncol. 2021;28.
    >> Share

  428. VEGA EA, Salehi O, Conrad C
    ASO Visual Abstract: Failure to Cure Patients with Colorectal Liver Metastases-The Impact of the Liver Surgeon.
    Ann Surg Oncol. 2021;28.
    >> Share

  429. JAYME VR, Fonseca GM, Amaral IMA, Coelho FF, et al
    ASO Visual Abstract: Infiltrative Tumor Borders in Colorectal Liver Metastasis: Should We Enlarge Margin Size?
    Ann Surg Oncol. 2021;28.
    >> Share

  430. GOLDBERG EM, Berger Y, Sood D, Kurnit KC, et al
    ASO Visual Abstract: Differences in Sociodemographic Disparities in Patients Undergoing Surgery for Advanced Colorectal and Ovarian Cancer.
    Ann Surg Oncol. 2021;28.
    >> Share

  431. SAWADA R, Akiyoshi T, Kitagawa Y, Hiyoshi Y, et al
    ASO Visual Abstract: Systemic Inflammatory Markers Combined with Tumor-Infiltrating Lymphocyte Density for the Improved Prediction of Response to Neoadjuvant Chemoradiotherapy in Rectal Cancer.
    Ann Surg Oncol. 2021;28.
    >> Share

  432. WIJSMULLER AR, Hemmer PHJ
    Snapshot Study on the Value of Omentoplasty in Abdominoperineal Resection with Primary Perineal Closure for Rectal Cancer.
    Ann Surg Oncol. 2021;28.
    >> Share

  433. KONG JC, Ngan S, Tie J, Heriot AG, et al
    Reply to: Does Total Neoadjuvant Treatment Improve Overall Survival in Rectal Cancer? No, It Does Not.
    Ann Surg Oncol. 2021;28.
    >> Share

  434. SOCHA J, Bujko K
    Does Total Neoadjuvant Treatment Improve Overall Survival in Rectal Cancer? No, It Does Not.
    Ann Surg Oncol. 2021;28.
    >> Share

  435. BAKKERS C, Lurvink RJ, van Erning FN, Nienhuijs SW, et al
    ASO Author Reflections: Treatment and Prognosis of Colorectal Peritoneal Metastases.
    Ann Surg Oncol. 2021;28:9084-9085.
    >> Share

  436. LINTIS A, Piessen G, Eveno C
    Together or Sequentially? A Curative Approach of Colorectal Liver and Peritoneal Metastasis Treatment is Possible.
    Ann Surg Oncol. 2021;28.
    >> Share

  437. ADILEH M, Laks S, Ben-Yaakov A, Nissan A, et al
    Response to: Concurrent or Sequential? A Curative Approach to Colorectal Liver and Peritoneal Metastasis Treatment is Possible.
    Ann Surg Oncol. 2021;28.
    >> Share

  438. HUISMAN JF, de Vos Tot Nederveen Cappel WH, van Westreenen HL
    ASO Author Reflections: Decline in Unnecessary Surgery by Structural Restaging After Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer.
    Ann Surg Oncol. 2021;28.
    >> Share

    November 2021
  439. VERHEIJ FS, Yuval JB, Soares KC, Garcia-Aguilar J, et al
    ASO Author Reflections: Hepatic Arterial Infusion Pump Can Be Placed Simultaneously with Primary Tumor Resection in Colon Cancer Patients with Synchronous Metastases.
    Ann Surg Oncol. 2021 Nov 17. pii: 10.1245/s10434-021-11043.
    >> Share

  440. MARKS VA, Hsiang WR, Umer W, Haleem A, et al
    Access to Colorectal Cancer Care for Medicaid-Insured Patients at Designated Cancer Facilities.
    Ann Surg Oncol. 2021 Nov 11. pii: 10.1245/s10434-021-11053.
    >> Share

  441. VERHEIJ FS, Soares KC, Beets GL, Kok NFM, et al
    Timing of Primary Tumor Resection in Synchronous Metastatic Colon Cancer Patients Undergoing Hepatic Arterial Infusion Pump Placement.
    Ann Surg Oncol. 2021 Nov 9. pii: 10.1245/s10434-021-11029.
    >> Share

  442. ZORRILLA-VACA A, Ripolles-Melchor J, Fernandez-Valdes P, Ruiz-Escobar A, et al
    Association of Liberal Fluid Therapy for Colorectal Cancer Surgery and Long-Term Oncologic Recurrence.
    Ann Surg Oncol. 2021 Nov 8. pii: 10.1245/s10434-021-11046.
    >> Share

  443. LIU W, Zhang W, Xu Y, Li YH, et al
    A Prognostic Scoring System to Predict Survival Outcome of Resectable Colorectal Liver Metastases in this Modern Era.
    Ann Surg Oncol. 2021;28:7709-7718.
    >> Share

  444. GOLDBERG EM, Berger Y, Sood D, Kurnit KC, et al
    Differences in Sociodemographic Disparities Between Patients Undergoing Surgery for Advanced Colorectal or Ovarian Cancer.
    Ann Surg Oncol. 2021;28:7795-7806.
    >> Share

  445. VEGA EA, Salehi O, Nicolaescu D, Dussom EM, et al
    Failure to Cure Patients with Colorectal Liver Metastases: The Impact of the Liver Surgeon.
    Ann Surg Oncol. 2021;28:7698-7706.
    >> Share

  446. VAN LOON YT, van Erning FN, Maas HA, Stassen LPS, et al
    Primary Anastomosis Versus End-Ostomy in Left-Sided Colonic and Proximal Rectal Cancer Surgery in the Elderly Dutch Population: A Propensity Score Matched Analysis.
    Ann Surg Oncol. 2021;28:7450-7460.
    >> Share

  447. KONG JC, Soucisse M, Michael M, Tie J, et al
    Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer: A Systematic Review and Metaanalysis of Oncological and Operative Outcomes.
    Ann Surg Oncol. 2021;28:7476-7486.
    >> Share

  448. JAYME VR, Fonseca GM, Amaral IMA, Coelho FF, et al
    Infiltrative Tumor Borders in Colorectal Liver Metastasis: Should We Enlarge Margin Size?
    Ann Surg Oncol. 2021;28:7636-7646.
    >> Share

  449. WILSON K, Heriot A
    ASO Author Reflections: Immunotherapy in Rectal Cancer Illusion or Nirvana.
    Ann Surg Oncol. 2021;28:7474-7475.
    >> Share

  450. VEGA EA, Freeman R, Conrad C
    Do We Still Need Liver Surgeons in the Treatment of Colorectal Liver Metastases?
    Ann Surg Oncol. 2021;28:7707-7708.
    >> Share

  451. SQUEO GC, Kane WJ, Hedrick TL
    Guide to Enhanced Recovery for Cancer Patients Undergoing Surgery: ERP and Colorectal Cancer Surgery.
    Ann Surg Oncol. 2021;28:6974-6977.
    >> Share

    October 2021
  452. CHAN AKC, Mason JM, Baltatzis M, Siriwardena AK, et al
    Management of Colorectal Cancer with Synchronous Liver Metastases: An Inception Cohort Study (CoSMIC).
    Ann Surg Oncol. 2021 Oct 30. pii: 10.1245/s10434-021-11017.
    >> Share

  453. HERBERT C, Paro A, Diaz A, Pawlik TM, et al
    ASO Visual Abstract: Association of Community Economic Distress and Breast and Colorectal Cancer Screening, Incidence, and Mortality Rates Among U.S. Counties.
    Ann Surg Oncol. 2021 Oct 27. pii: 10.1245/s10434-021-10942.
    >> Share

  454. KONISHI T, Rodriguez-Bigas MA
    Primary Tumor Resection in Colorectal Cancer with Unresectable Synchronous Metastasis: Time to Reconsider the Role of the Surgeon.
    Ann Surg Oncol. 2021 Oct 20. pii: 10.1245/s10434-021-10949.
    >> Share

  455. LEE SJ, Jeon Y, Lee HW, Kang J, et al
    Impact of Mitomycin-C-Induced Neutropenia after Hyperthermic Intraperitoneal Chemotherapy with Cytoreductive Surgery in Colorectal Cancer Patients with Peritoneal Carcinomatosis.
    Ann Surg Oncol. 2021 Oct 19. pii: 10.1245/s10434-021-10924.
    >> Share

  456. FLOOD M, Narasimhan V, Wilson K, Lim WM, et al
    ASO Visual Abstract: Organoids as a Robust Preclinical Model for Precision Medicine in Colorectal Cancer-A Systematic Review.
    Ann Surg Oncol. 2021 Oct 18. pii: 10.1245/s10434-021-10926.
    >> Share

  457. FROMER MW, Scoggins CR, Egger ME, Philips P, et al
    ASO Visual Abstract: Preventing Futile Liver Resection: A Risk-Based Approach to Surgical Selection in Major Hepatectomy for Colorectal Cancer.
    Ann Surg Oncol. 2021 Oct 4. pii: 10.1245/s10434-021-10841.
    >> Share

  458. FLOOD M, Narasimhan V, Wilson K, Lim WM, et al
    Organoids as a Robust Preclinical Model for Precision Medicine in Colorectal Cancer: A Systematic Review.
    Ann Surg Oncol. 2021 Oct 1. pii: 10.1245/s10434-021-10829.
    >> Share

  459. HIDA K, Nishizaki D, Sumii A, Okamura R, et al
    Prognostic Impact of Lateral Pelvic Node Dissection on the Survival of Patients in Low Rectal Cancer Subgroups Based on Lymph Node Size.
    Ann Surg Oncol. 2021;28:6179-6188.
    >> Share

  460. JIANG W, Li M, Tan J, Feng M, et al
    A Nomogram Based on a Collagen Feature Support Vector Machine for Predicting the Treatment Response to Neoadjuvant Chemoradiotherapy in Rectal Cancer Patients.
    Ann Surg Oncol. 2021;28:6408-6421.
    >> Share

  461. SAWADA R, Akiyoshi T, Kitagawa Y, Hiyoshi Y, et al
    Systemic Inflammatory Markers Combined with Tumor-Infiltrating Lymphocyte Density for the Improved Prediction of Response to Neoadjuvant Chemoradiotherapy in Rectal Cancer.
    Ann Surg Oncol. 2021;28:6189-6198.
    >> Share

  462. THIAGARAJAN S, Tan JW, Zhou S, Tan QX, et al
    Postoperative Inflammatory Marker Surveillance in Colorectal Peritoneal Carcinomatosis.
    Ann Surg Oncol. 2021;28:6625-6635.
    >> Share

  463. ROSATI A, Vargiu V, Santullo F, Lodoli C, et al
    Rectosigmoid Mesorectal-Sparing Resection in Advanced Ovarian Cancer Surgery.
    Ann Surg Oncol. 2021;28:6721-6722.
    >> Share

  464. HERBERT C, Paro A, Diaz A, Pawlik TM, et al
    ASO Author Reflections: Association of Community Economic Distress and Breast and Colorectal Cancer Screening, Incidence, and Mortality Rates among U.S. Counties.
    Ann Surg Oncol. 2021 Oct 1. pii: 10.1245/s10434-021-10864.
    >> Share

  465. CHOI GS
    Lateral Pelvic Node Metastasis in Locally Advanced Rectal Cancer: Are We Exaggerating or Ignoring?
    Ann Surg Oncol. 2021;28:5803-5804.
    >> Share

  466. YASHIMA-ABO A, Otsuka K, Nishizuka SS
    Editorial Comment to "A nomogram Based on a Collagen Feature Support Vector Machine for Predicting the Treatment Response to Neoadjuvant Chemoradiotherapy in Rectal Cancer Patients".
    Ann Surg Oncol. 2021;28:5818-5819.
    >> Share

  467. SAWADA R, Akiyoshi T
    ASO Author Reflections: Combinations of Systemic Inflammatory Markers and CD8+ Tumor-infiltrating Lymphocyte Density: Predictive Utility for Response to Neoadjuvant Chemoradiotherapy in Rectal Cancer.
    Ann Surg Oncol. 2021;28:6199-6200.
    >> Share

  468. TAN JW, Thiagarajan S, Zhou S, Tan QX, et al
    ASO Author Reflections: Postoperative Inflammatory Markers as a Surveillance Tool in Colorectal Peritoneal Carcinomatosis.
    Ann Surg Oncol. 2021;28:6636-6637.
    >> Share

  469. JIANG W, Gao Y, Zhuo S, Yan J, et al
    ASO Author Reflections: Prediction of Treatment Response to Neoadjuvant Chemoradiotherapy Based on a Collagen Features Model in Rectal Cancer Patients.
    Ann Surg Oncol. 2021;28:6422-6423.
    >> Share

  470. MUADDI H, Karanicolas P
    ASO Author Reflections: Disappearing Liver Metastases: Should We Be Afraid of the Dark?
    Ann Surg Oncol. 2021;28:6814-6815.
    >> Share

    September 2021
  471. HERBERT C, Paro A, Diaz A, Pawlik TM, et al
    Association of Community Economic Distress and Breast and Colorectal Cancer Screening, Incidence, and Mortality Rates Among US Counties.
    Ann Surg Oncol. 2021 Sep 28. pii: 10.1245/s10434-021-10849.
    >> Share

  472. LIVINGSTON AJ, Bailey CE
    Invited Editorial: Does Side Really Matter? Survival Analysis Among Patients with Right- Versus Left-Sided Colon Cancer: A Propensity Score-Adjusted Analysis.
    Ann Surg Oncol. 2021 Sep 24. pii: 10.1245/s10434-020-09522.
    >> Share

  473. ROMESSER PB, Crane CH
    Chemo-Re-Irradiation and Salvage Surgery for Locally Recurrent Rectal Cancer.
    Ann Surg Oncol. 2021;28:4769-4771.
    >> Share

  474. CEELEN W
    Intraperitoneal EpCAM-Targeted Immunotoxin: A First Step Towards Engineering the Immune Environment in Colorectal Peritoneal Metastases?
    Ann Surg Oncol. 2021;28:4772-4774.
    >> Share

  475. FLANAGAN M, Clancy C, Burke J
    ASO Author Reflections: Clinical Benefit of Neoadjuvant Short-Course Radiotherapy for Upper-Third Rectal Tumors over Surgery Alone.
    Ann Surg Oncol. 2021;28:5250-5251.
    >> Share

  476. LAKS S, Adileh M, Ben-Yaacov A, Nissan A, et al
    ASO Author Reflections: If Once Is Good, Is Twice Just as Good? A critical evaluation of Repeat CRS-HIPEC for Colorectal Peritoneal Metastases.
    Ann Surg Oncol. 2021;28:5339-5340.
    >> Share

  477. ROVERS KP, Lurvink RJ, Nienhuijs SW, de Hingh IHJT, et al
    ASO Author Reflections: PIPAC for Unresectable Colorectal Peritoneal Metastases.
    Ann Surg Oncol. 2021;28:5327-5329.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016